Page last updated: 2024-10-17

lactic acid and Alloxan Diabetes

lactic acid has been researched along with Alloxan Diabetes in 248 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"To investigate the inhibitory effects of 25-hydroxyvitamin D3 (25(OH)D3)-loaded polylactic acid (PLA) microspheres on inflammatory response in diabetic periodontitis."7.80Attenuation of inflammatory response by 25- hydroxyvitamin D3-loaded polylactic acid microspheres in treatment of periodontitis in diabetic rats. ( Chen, XM; Li, B; Li, H; Li, W; Wang, Q; Xiao, Y, 2014)
" However, low peroral bioavailability is a major limiting factor for the success of clinical utilization of curcumin."5.39Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model. ( Balakrishna, N; Grama, CN; Kumar, MN; Patil, MA; Raghu, G; Reddy, GB; Suryanarayana, P, 2013)
"To investigate the inhibitory effects of 25-hydroxyvitamin D3 (25(OH)D3)-loaded polylactic acid (PLA) microspheres on inflammatory response in diabetic periodontitis."3.80Attenuation of inflammatory response by 25- hydroxyvitamin D3-loaded polylactic acid microspheres in treatment of periodontitis in diabetic rats. ( Chen, XM; Li, B; Li, H; Li, W; Wang, Q; Xiao, Y, 2014)
" It was found that the development of diabetes mellitus is associated with dramatic changes in the metabolism of blood cells and kidney tissue: inhibition of aerobic ATP synthesis, accumulation of lactate, uncoupling of oxidative phosphorylation, and development of lactic acidosis."3.79Dysfunction of membrane-receptor system of blood cells and kidney tissue in experimental diabetes mellitus. ( Gurina, AE; Mikaelian, NP; Terent'ev, AA, 2013)
" In this study we evaluated the effect of global brain ischemia on brain metabolic parameters in normal and diabetic rats treated with a dihydropyridine calcium antagonist, felodipine."3.72The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers. ( Dunbar, JC; Levy, J; Zhu, Z, 2004)
" We assessed the effect of a novel oral antilipolytic agent, N-[(1S, trans)-2-hydroxycyclopentyl]adenosine (GR 79236), in experimental diabetic ketoacidosis."3.69Improvement of ketoacidosis in the diabetic rat after the administration of the oral antilipolytic agent GR 79236. ( Mikhailidis, DP; Strong, P; Thompson, CS, 1994)
""In vitro" isometric developed tension (IDT) and frequency of contractions (FC), glucose (Glu), glycogen (GLY) and triglyceride (TG) metabolism, as well as prostaglandin PGE2 and PGE1 production, were studied in uterine strips and in embryos isolated from controls and diabetic rats at day 10 of pregnancy."3.68Glucose, glycogen and triglyceride metabolism, as well as prostaglandin production in uterine strips and in embryos from diabetic pregnant rats. Influences of the presence of substrate in the incubation medium. ( Catafau, JR; Gimeno, AL; Gimeno, MA; Gomez, G; Gonzalez, ET; Jawerbaum, A; Rodriguez, RR, 1993)
" The pharmacological availability (PA%) and bioavailability (FR%) for insulin-loaded ChAuNps/PLGA were 15."1.72Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery. ( Asal, HA; El-Hagrasy, MA; Shoueir, KR; Toson, EA, 2022)
"Treatment with metformin improved these parameters."1.62Metformin mitigates impaired testicular lactate transport/utilisation and improves sexual behaviour in streptozotocin-induced diabetic rats. ( Abu Bakar, AB; Ahmad, A; Mohamed, M; Nna, VU, 2021)
" However, this system presents a bioavailability of less than 20% for insulin encapsulation."1.48Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. ( Auberval, N; Bietiger, W; Czuba, E; Diop, M; Frere, Y; Julien-David, D; Langlois, A; Maillard, E; Marchioni, E; Mura, C; Neidl, R; Pinget, M; Schaschkow, A; Sigrist, S; Virciglio, A, 2018)
"Cerebral ischemia is a serious possible manifestation of diabetic vascular disease."1.48Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats. ( Dave, KR; Perez-Pinzon, MA; Rehni, AK; Shukla, V, 2018)
"To improve insulin bioavailability and overcome multiple barriers for oral delivery of insulin, the composite nanocarriers (PLGA/FA-CS) prepared from poly(lactide-co-glycoside) (PLGA) and folic acid modified chitosan (FA-CS) were fabricated via electrostatic self-assembly method."1.46Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin. ( Jiang, G; Kong, X; Liu, D; Liu, Y; Xu, B; Yao, J; Yu, W, 2017)
" It is obvious that patient compliance can be improved greatly if insulin could be formulated in an oral dosage form."1.43Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation. ( Abnous, K; Alabdollah, F; Alibolandi, M; Hadizadeh, F; Mohammadi, M; Ramezani, M; Sadeghi, F, 2016)
" These results suggest that the developed platform has great potential to enhance the efficacy for implants in cases where the cell dosage is critical for efficacy, such as islet transplantation and ischemic tissues."1.43Improvement of islet engrafts by enhanced angiogenesis and microparticle-mediated oxygenation. ( Ashtiani, MK; Baharvand, H; Bonakdar, S; Hajizadeh-Saffar, E; Hojjati-Emami, S; Montazeri, L; Najar-Asl, M; Noori-Keshtkar, M; Tahamtani, Y, 2016)
" In addition, GCMs had a longer interval between dosing (two weeks) and a lower dosage(2."1.43Effects of Pluronic F127-PEG multi-gel-core on the release profile and pharmacodynamics of Exenatide loaded in PLGA microspheres. ( Cai, C; Gong, H; Gou, J; Ren, T; Tang, X; Wang, P; Wang, Q; Zhang, Y, 2016)
" Once the MS were optimised, the target loading of rhEGF was increased to 1% (PLGA-Alginate MS), and particles were sterilised by gamma radiation to provide the correct dosage for in vivo studies."1.39rhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats. ( Aguirre, JJ; Gainza, G; Hernández, RM; Igartua, M; Pedraz, JL, 2013)
" However, low peroral bioavailability is a major limiting factor for the success of clinical utilization of curcumin."1.39Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model. ( Balakrishna, N; Grama, CN; Kumar, MN; Patil, MA; Raghu, G; Reddy, GB; Suryanarayana, P, 2013)
" Nanoparticle insulin results in six fold increase in oral bioavailability to that of plain insulin in healthy rats."1.39Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics. ( Ravi Kumar, MN; Sharma, G; van der Walle, CF, 2013)
"FA-PEG-PLGA NPs (50 U/kg) exhibited a twofold increase in the oral bioavailability (double hypoglycemia) without any hypoglycemic shock as compared to subcutaneously administered standard insulin solution."1.38Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. ( Das, M; Godugu, C; Jain, AK; Jain, S; Rathi, VV, 2012)
"Titanium implants were planted into the tibias of the diabetic rats and into 10 normal rats."1.38Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats. ( Deng, ZX; Li, DH; Liang, LH; Song, YL; Sun, DC; Yu, M; Zhou, W; Zhu, WZ; Zou, GK, 2012)
"Despite treatment, this syndrome complicated the interpretation of blood glucose readings as a measure of islet graft function and resulted in death or the need for euthanasia in all seven animals."1.38A syndrome of severe hypoglycemia and acidosis in young immunosuppressed diabetic monkeys and pigs-association with sepsis. ( Bottino, R; Cooper, DK; Dons, EM; Echeverri, GJ; Rigatti, LH; van der Windt, DJ; Wagner, R; Wijkstrom, M; Zhou, H, 2012)
" Pharmacokinetic analysis demonstrated that insulin administered in PLGA microcapsules illustrated a sustained release profile which resulted in a longer mean residence time, 4 and 5 fold longer than those after pulmonary administration of RSDI and SC injection of NPH insulin, respectively."1.36Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats. ( Emami, J; Gilani, K; Hamishehkar, H; Hassanzadeh, K; Koohsoltani, M; Mahdavi, H; Minaiyan, M; Najafabadi, AR; Nokhodchi, A, 2010)
" Surface-modified NPs could be used to improve patient compliance with drug treatment as a result of decreased dosing frequency."1.35Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus. ( Jain, S; Saraf, S, 2009)
" The pharmacological effect of PLGA/HPbetaCD/insulin LPP was confirmed by dose-response studies performed on both normoglycaemic and streptozotocin-induced diabetic rats."1.35Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. ( d'Emmanuele di Villa Bianca, R; Giovino, C; La Rotonda, MI; Miro, A; Quaglia, F; Sorrentino, R; Ungaro, F, 2009)
" The relative bioavailability of PNP and PHNP compared with subcutaneous (s."1.34Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. ( Cui, FD; Cun, DM; Shi, K; Tao, AJ; Zhang, LQ, 2007)
"7% of oral bioavailability relative to subcutaneous injection was obtained."1.33Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. ( Cui, F; Kawashima, Y; Shi, K; Tao, A; Zhang, L, 2006)
" Multiple dosing given every 10 days demonstrated that the pharmacological effect and serum insulin levels from second or third doses were similar and comparable to that of the first dose."1.32Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. ( DeLuca, PP; Jiang, G; Qiu, W, 2003)
"Stress hyperglycemia is frequent in critically ill patients."1.32Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. ( Coopmans, W; Giulietti, AP; Mathieu, C; Michalaki, M; Van den Berghe, G; Van Herck, E; Weekers, F, 2003)
"01) and the relative pharmacological bioavailability is (10."1.31[Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles]. ( Pan, Y; Wei, G; Xu, H; Zhao, HY; Zheng, JM, 2002)
" The release profile of the microcapsules was designed to mimic a dosing regimen of multiple injections of TAK-778 solution."1.31Enhancement of fracture repair in rats with streptozotocin-induced diabetes by a single injection of biodegradable microcapsules containing a bone formation stimulant, TAK-778. ( Hoshino, T; Makino, H; Muranishi, H; Nagai, H; Notoya, K; Ogawa, Y; Saito, K; Sohda, T, 2000)
"Lactic acidosis has been implicated; however, increases in the excitotoxic amino acid glutamate, which correlate with increased neuronal damage, may be the cause for the increased damage seen in hyperglycemic stroke."1.31The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. ( Diaz, FG; Guyot, LL; O'Regan, MH; Phillis, JW; Song, D, 2001)
"In conclusion, 12 weeks of streptozotocin diabetes in swine caused a significant decrease in myocardial GLUT4 protein and a decrease in myocardial glucose uptake during ischemia."1.30Decreased myocardial glucose uptake during ischemia in diabetic swine. ( Hacker, TA; Hall, JL; Hernandez, LA; Stanley, WC; Whitesell, LF, 1997)
"Alloxan treatment reduced nitric oxide generation, whereas L-arginine and sodium nitroprusside, when given along with alloxan, enhanced nitric oxide production to control values."1.30Effect of L-arginine-nitric oxide system on chemical-induced diabetes mellitus. ( Das, UN; Mohan, IK, 1998)
"3."1.29Chronic gliclazide treatment affects basal and post-ischemic cardiac function in diabetic rats. ( Mimura, G; Murakami, K; Nagamine, F; Oshiro, K; Shimabukuro, M, 1994)
" In accordance with the polyol theory, the chronic administration of SDI 157 to diabetic rats accelerated the cataract development and depleted the lens of total and oxidized glutathione."1.29Sorbitol-accumulating pyrimidine derivatives. ( Geisen, K; Grötsch, H; Lang, HJ; Nimmesgern, H; Utz, R, 1994)
"Glycerol was the best substrate for D-lactate formation via methylglyoxal in rat liver."1.29Carbon sources for D-lactate formation in rat liver. ( Hirata, M; Kawase, M; Kondoh, Y; Ohmori, S, 1994)
" Insulin from the PIS device maintained normal blood glucose levels for 10 d in diabetic rats as an implantable dosage form."1.29Controlled release of insulin from plasma-irradiated sandwitch device using poly-DL-lactic acid. ( Kuzuya, M; Matsuno, Y; Watanabe, S; Yamakawa, I, 1993)
"Plasma glucose in NIDDM rats was elevated (P less than 0."1.28Effect of insulin on glucose utilization in epitrochlearis muscle of rats with streptozocin-induced NIDDM. ( Gavin, JR; Karl, IE; Levy, J, 1990)
" Furthermore, 2-deoxyglucose uptake in CS-045-treated adipocytes was increased and the insulin dose-response curve was shifted to the left."1.27Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. ( Fujiwara, T; Horikoshi, H; Ushiyama, I; Yoshioka, S; Yoshioka, T, 1988)

Research

Studies (248)

TimeframeStudies, this research(%)All Research%
pre-199041 (16.53)18.7374
1990's45 (18.15)18.2507
2000's65 (26.21)29.6817
2010's81 (32.66)24.3611
2020's16 (6.45)2.80

Authors

AuthorsStudies
Hao, Q1
Huang, Z1
Li, Q1
Liu, D2
Wang, P3
Wang, K1
Li, J2
Cao, W2
Deng, W1
Wu, K1
Su, R1
Liu, Z1
Vadgama, J1
Wu, Y2
Li, M1
Wang, S1
Liu, X2
Sheng, Z1
Li, B3
Zhang, J1
Zhang, Z4
Asal, HA1
Shoueir, KR1
El-Hagrasy, MA1
Toson, EA1
Zhao, L3
Jiang, H1
Xie, J1
Shen, D1
Yi, Q1
Yan, J1
Li, C2
Zheng, H3
Gao, H3
Pang, H1
Huang, X1
Xu, ZP1
Chen, C1
Han, FY1
Li, X2
Zhang, Y2
Xu, L1
Wang, A1
Zou, Y1
Li, T1
Huang, L2
Chen, W1
Liu, S1
Jiang, K1
Zhang, X2
Wang, D2
Zhang, L4
Chen, X1
Jia, W2
Zhao, A1
Yan, X1
Zhou, H2
Zhu, L1
Ma, X1
Ju, Z1
Wang, C1
Loscalzo, J1
Yang, Y1
Zhao, Y1
Choi, YS1
Song, JE1
Kim, E1
Kim, CH1
Lee, JE1
Song, HT1
Choubey, M1
Ranjan, A1
Bora, PS1
Krishna, A1
Nna, VU2
Bakar, ABA1
Ahmad, A2
Umar, UZ1
Suleiman, JB1
Zakaria, Z1
Othman, ZA1
Mohamed, M2
Wang, SY1
Zhu, S1
Wu, J2
Zhang, M1
Xu, Y1
Xu, W1
Cui, J1
Yu, B1
Liu, J2
Zhu, Y2
Han, XQ1
Sun, XJ1
Yang, R1
Ma, WQ1
Liu, NF1
Mato Mofo, EP1
Essop, MF1
Owira, PMO1
Jha, MK2
Ament, XH1
Yang, F1
Liu, Y2
Polydefkis, MJ1
Pellerin, L1
Morrison, BM1
Bhusal, A1
Rahman, MH2
Lee, WH1
Lee, IK2
Suk, K2
Ikeda, H1
Yamamoto, S1
Kamei, J1
Nørlinger, TS1
Nielsen, PM2
Qi, H1
Mikkelsen, E1
Hansen, K1
Schmidt, NH1
Pedersen, M3
Agger, P1
Palm, F2
Laustsen, C3
Xu, B1
Jiang, G2
Yu, W1
Kong, X1
Yao, J1
Joshi, D1
Sarkar, D1
Singh, SK1
Wu, MC1
Ye, WR1
Zheng, YJ1
Zhang, SS1
Liu, L1
Tan, J1
Xie, Q1
Sun, J1
Pu, H1
Zhang, H2
Wang, W2
Li, H5
Peng, Y1
Wu, JZ1
Williams, GR2
Li, HY1
Wang, DX1
Li, SD1
Zhu, LM2
Tan, N1
Zhou, Y1
Wei, H1
Ren, S1
Yu, F1
Chen, H1
Jia, C1
Yang, G1
Song, Y1
Shi, Y2
Xue, J1
Jia, L1
Du, Q1
Niu, J1
Zhang, D1
Pham, TT1
Nguyen, TT1
Pathak, S1
Regmi, S1
Nguyen, HT1
Tran, TH1
Yong, CS1
Kim, JO1
Park, PH1
Park, MH1
Bae, YK1
Choi, JU1
Byun, Y1
Ahn, CH1
Yook, S1
Jeong, JH1
Han, H1
Lee, JS1
Kim, H1
Shin, S1
Lee, J1
Kim, J1
Hou, X1
Cho, SW1
Seo, J1
Lee, T1
Morze, CV1
Allu, PKR1
Chang, GY1
Marco-Rius, I1
Milshteyn, E1
Wang, ZJ1
Ohliger, MA1
Gleason, CE1
Kurhanewicz, J1
Vigneron, DB1
Pearce, D1
Czuba, E1
Diop, M1
Mura, C1
Schaschkow, A1
Langlois, A1
Bietiger, W1
Neidl, R1
Virciglio, A1
Auberval, N1
Julien-David, D1
Maillard, E1
Frere, Y2
Marchioni, E2
Pinget, M2
Sigrist, S2
Rehni, AK1
Shukla, V1
Perez-Pinzon, MA1
Dave, KR1
Hassanin, KMA1
Mahmoud, MO1
Hassan, HM1
Abdel-Razik, AH1
Aziz, LN1
Rateb, ME1
Frigero, M1
Dos Santos, SA1
Serra, AJ1
Dos Santos Monteiro Machado, C1
Portes, LA1
Tucci, PJF1
Silva, F1
Leal-Junior, EC1
de Carvalho, PTC1
Dong, M1
Ren, M1
Xie, S1
Gong, YC1
Xiong, XY1
Li, ZL1
Luo, YY1
Li, YP1
Ruegsegger, GN1
Manjunatha, S1
Summer, P1
Gopala, S1
Zabeilski, P1
Dasari, S1
Vanderboom, PM1
Lanza, IR1
Klaus, KA1
Nair, KS1
Rastegari, A1
Mottaghitalab, F1
Dinarvand, R2
Amini, M1
Arefian, E1
Gholami, M1
Atyabi, F2
Abu Bakar, AB1
Lipsø, K1
Østergaard, JA2
Bertelsen, LB1
Flyvbjerg, A2
Ardenkjær-Larsen, JH1
Bomba, M1
Ciavardelli, D1
Silvestri, E1
Canzoniero, LM1
Lattanzio, R1
Chiappini, P1
Piantelli, M1
Di Ilio, C1
Consoli, A1
Sensi, SL1
Wang, Q4
Xiao, Y3
Bao, C2
Li, W2
Mikaelian, NP1
Gurina, AE1
Terent'ev, AA1
Dang, TT1
Thai, AV1
Cohen, J1
Slosberg, JE1
Siniakowicz, K1
Doloff, JC1
Ma, M1
Hollister-Lock, J1
Tang, KM1
Gu, Z2
Cheng, H1
Weir, GC1
Langer, R1
Anderson, DG1
Arantes, LM1
Bertolini, NO1
de Moura, RF1
de Mello, MA3
Luciano, E3
Gainza, G1
Aguirre, JJ1
Pedraz, JL1
Hernández, RM1
Igartua, M1
Chan, O1
Paranjape, SA1
Horblitt, A1
Zhu, W1
Sherwin, RS1
Sanches, IC1
Conti, FF1
Sartori, M1
Irigoyen, MC1
De Angelis, K1
Grama, CN1
Suryanarayana, P1
Patil, MA1
Raghu, G1
Balakrishna, N1
Kumar, MN1
Reddy, GB1
Di, J1
Price, J1
Gu, X1
Jiang, X1
Jing, Y1
Arbeláez, AM1
Cryer, PE1
Aveseh, M1
Nikooie, R2
Sheibani, V1
Esmaeili-Mahani, S1
Shahverdi, S1
Hajimiri, M1
Esfandiari, MA1
Larijani, B1
Rajabiani, A1
Dehpour, AR1
Gharehaghaji, AA1
Daneshyar, S1
Gharakhanlou, R1
Forutan, Y1
Patterson, E1
Marques, TM1
O'Sullivan, O1
Fitzgerald, P1
Fitzgerald, GF1
Cotter, PD1
Dinan, TG1
Cryan, JF1
Stanton, C1
Ross, RP1
Lee, CH2
Chang, SH2
Chen, WJ2
Hung, KC2
Lin, YH1
Liu, SJ2
Hsieh, MJ1
Pang, JH1
Juang, JH2
Chen, XM1
Rawat, S1
Gupta, P1
Kumar, A1
Garg, P1
Suri, CR1
Sahoo, DK1
Corvino, SB1
Netto, AO1
Sinzato, YK1
Campos, KE1
Calderon, IM1
Rudge, MV1
Volpato, GT1
Zambrano, E1
Damasceno, DC1
Malathi, S1
Nandhakumar, P1
Pandiyan, V1
Webster, TJ1
Balasubramanian, S1
Chien, CT1
Jou, MJ1
Cheng, TY1
Yang, CH1
Yu, TY1
Li, PC1
Sheng, J2
Han, L2
Qin, J2
Ru, G2
Li, R2
Wu, L1
Cui, D1
Yang, P2
He, Y1
Wang, J2
Liu, KS1
Pang, JS1
Chou, CC1
Chang, PC1
Chen, YT1
Wang, FS1
Kim, JH1
Nam, Y1
Lee, MG1
Go, Y1
Harris, RA1
Park, DH1
Kook, H1
Alibolandi, M1
Alabdollah, F1
Sadeghi, F1
Mohammadi, M1
Abnous, K1
Ramezani, M1
Hadizadeh, F1
Montazeri, L1
Hojjati-Emami, S1
Bonakdar, S1
Tahamtani, Y1
Hajizadeh-Saffar, E1
Noori-Keshtkar, M1
Najar-Asl, M1
Ashtiani, MK1
Baharvand, H1
Liao, H1
He, H2
Chen, S1
Yang, VC1
Branford-White, C1
Li, Y1
Wang, Y2
Deng, GG1
Davies, KP1
Ren, T1
Gong, H1
Gou, J1
Cai, C1
Tang, X1
Lin, X1
Tang, S1
Zhou, Q1
Lin, Q1
S, S2
S, M1
P S L, S1
S, B1
V, P1
Sun, S2
Liang, N2
Gong, X1
An, W1
Kawashima, Y3
Cui, F3
Yan, P1
Verbeke, CS1
Gordo, S1
Schubert, DA1
Lewin, SA1
Desai, RM1
Dobbins, J1
Wucherpfennig, KW1
Mooney, DJ1
Haggag, YA1
Faheem, AM1
Tambuwala, MM1
Osman, MA1
El-Gizawy, SA1
O'Hagan, B1
Irwin, N1
McCarron, PA1
Palanivel, R1
Vu, V1
Park, M1
Fang, X1
Sweeney, G1
Naha, PC2
Kanchan, V2
Panda, AK2
Dong, X1
Xu, J1
Luo, H1
Liang, X1
Wang, H1
Chang, J1
Mao, GH1
Chen, GA1
Bai, HY1
Song, TR1
Wang, YX1
Ungaro, F1
d'Emmanuele di Villa Bianca, R1
Giovino, C1
Miro, A1
Sorrentino, R1
Quaglia, F1
La Rotonda, MI1
Gomes, RJ1
de Oliveira, CA2
Ribeiro, C1
Mota, CS1
Moura, LP1
Tognoli, LM1
Leme, JA1
Gao, Z1
Tang, Y1
Chen, J1
Bai, R1
Zhang, Q1
Hou, Y1
Lu, Y3
Bai, G1
Wang, SL1
Xie, SY1
Zhu, LY1
Wang, FH1
Zhou, WZ1
Piao, H1
Yamamoto, H1
Hamishehkar, H1
Emami, J1
Najafabadi, AR1
Gilani, K1
Minaiyan, M1
Hassanzadeh, K1
Mahdavi, H1
Koohsoltani, M1
Nokhodchi, A1
Yu, M2
Hui, XM1
Wang, F1
Zhang, N1
Zhang, HP1
Song, YL2
Pinto, E1
Zhang, B1
Song, S1
Bodor, N1
Buchwald, P1
Hochhaus, G1
Jain, S2
Saraf, S1
Contarteze, RV1
de Alencar Mota, CS1
de Almeida Leme, JA1
Bottcher, LB1
Santiago, AR1
Garrido, MJ1
Cristóvão, AJ1
Duarte, JM1
Carvalho, RA1
Ambrósio, AF1
Liu, B1
Dong, Q1
Wang, M1
Shi, L1
Yu, X1
Shan, Y1
Jiang, C1
Gu, T1
Chen, Y1
Kong, W1
Lin, MH1
Chen, HY1
Liao, TH1
Huang, TC1
Chen, CM1
Lee, JA2
Hazekawa, M1
Sakai, Y1
Yoshida, M1
Haraguchi, T1
Morisaki, T1
Uchida, T1
Ataman, OV1
Ataman, IuO1
Bowers, DT1
Chhabra, P1
Langman, L1
Botchwey, EA1
Brayman, KL1
Yang, J1
Sun, H1
Song, C1
Sharma, G1
van der Walle, CF1
Ravi Kumar, MN1
Wu, ZM1
Zhou, L1
Guo, XD1
Jiang, W1
Ling, L1
Qian, Y1
Luo, KQ1
Zhang, LJ1
Glaser, N1
Ngo, C1
Anderson, S1
Yuen, N1
Trifu, A1
O'Donnell, M1
Bicer, M1
Gunay, M1
Baltaci, AK1
Uney, K1
Mogulkoc, R1
Akil, M1
Rathi, VV1
Jain, AK1
Das, M1
Godugu, C1
Han, Y1
Zeng, Q1
E, L1
Liu, H1
Zou, GK1
Zhou, W2
Liang, LH1
Sun, DC1
Li, DH1
Deng, ZX1
Zhu, WZ1
Reix, N1
Parat, A1
Seyfritz, E1
Van der Werf, R1
Epure, V1
Ebel, N1
Danicher, L1
Jeandidier, N1
Park, W1
Kim, D1
Kang, HC1
Bae, YH1
Na, K1
Jain, R1
Agarwal, A1
Kierski, PR1
Schurr, MJ1
Murphy, CJ1
McAnulty, JF1
Abbott, NL1
van der Windt, DJ1
Dons, EM1
Rigatti, LH1
Echeverri, GJ1
Bottino, R1
Wijkstrom, M1
Wagner, R1
Cooper, DK1
Lauritzen, MH1
Nørregaard, R1
Bowen, S1
Søgaard, LV1
Ardenkjaer-Larsen, JH1
Papadimitrakopoulos, F1
Burgess, DJ1
Pósa, I1
Kocsis, E1
Nieszner, E1
Pogátsa, G1
Koltai, MZ1
Pan, Y2
Xu, H2
Zhao, HY1
Wei, G1
Zheng, JM2
Enoki, T1
Yoshida, Y1
Hatta, H1
Bonen, A2
Qiu, W1
DeLuca, PP1
Shenoy, DB1
D'Souza, RJ1
Tiwari, SB1
Udupa, N1
Linke, A1
Zhao, G1
Recchia, FA1
Williams, J1
Xu, X1
Hintze, TH1
Weekers, F1
Giulietti, AP1
Michalaki, M1
Coopmans, W1
Van Herck, E1
Mathieu, C1
Van den Berghe, G1
THIELMANN, K1
FRUNDER, H1
RICHTER, G1
BOERNIG, H1
Li, YJ1
Gao, P1
Ding, PT1
BAKER, N1
CHAIKOFF, IL1
SCHUSDEK, A1
Casson, RJ1
Chidlow, G1
Wood, JP1
Osborne, NN1
Malaisse, WJ3
Willem, R1
Kwon, YM1
Kim, SW1
Takenaga, M3
Yamaguchi, Y3
Kitagawa, A3
Ogawa, Y4
Kawai, S1
Mizushima, Y3
Igarashi, R3
Levy, J2
Zhu, Z1
Dunbar, JC1
Ayalasomayajula, SP2
Kompella, UB2
Hinds, KD1
Campbell, KM1
Holland, KM1
Lewis, DH1
Piché, CA1
Schmidt, PG1
Morel, S1
Berthonneche, C1
Tanguy, S1
Toufektsian, MC1
Perret, P1
Ghezzi, C1
de Leiris, J1
Boucher, F1
Yamazaki, RK1
Hirabara, SM1
Tchaikovski, OJ1
Lopes, MC1
Nogata, C1
Aikawa, J1
Nunes, EA1
Tanhoffer, RA1
Lissa, MD1
Fernandes, LC2
Sailaja Devi, MM1
Das, UN3
Suresh, Y1
Fu, Y1
Hu, B1
Tang, Q1
Fu, Q1
Xiang, J1
Coffe, V2
Carbajal, RC1
Salceda, R2
Amrite, AC1
Cheruvu, NP1
Diederen, RM1
Starnes, CA1
Berkowitz, BA1
Winkler, BS1
Baker, DJ1
Greenhaff, PL1
MacInnes, A1
Timmons, JA1
Christopher, M1
Rantzau, C1
Chen, ZP1
Snow, R1
Kemp, B1
Alford, FP1
Shi, K2
Tao, A1
Kumar, PS1
Ramakrishna, S1
Saini, TR1
Diwan, PV1
Yin, DF1
Wu, C1
Zhong, YQ1
Cui, FD1
Tao, AJ1
Cun, DM1
Zhang, LQ1
Zhang, SM1
Chen, PP1
Cheng, L1
Tang, WX1
Chen, ZW1
Ke, CM1
L'Abbate, A1
Neglia, D1
Vecoli, C1
Novelli, M1
Ottaviano, V1
Baldi, S1
Barsacchi, R1
Paolicchi, A1
Masiello, P1
Drummond, GS1
McClung, JA1
Abraham, NG1
Vial, G1
Dubouchaud, H1
Couturier, K1
Lanson, M1
Leverve, X1
Demaison, L1
Ozkaya, YG1
Ağar, A1
Hacioğlu, G1
Yargiçoğlu, P1
Yin, D1
Zhang, G1
Zou, H1
Sun, D1
Zhong, Y1
Manna, PK1
Inamasu, M1
Totsuka, T1
Morita, T1
Takeyama, S1
Hutson, JC1
Greene, DA2
Lattimer, SA1
Kliegman, RM1
Miettinen, EL1
Tserng, KY1
Stevenson, RW2
Orskov, H1
Parsons, JA2
Alberti, KG3
Freyse, EJ1
Fischer, U1
Albrecht, G1
Chiasson, JL1
Germain, L1
Srivastava, AK1
Dupuis, P1
Riquelme, PT1
Wernette-Hammond, ME1
Kneer, NM1
Lardy, HA1
Vary, TC1
Randle, PJ1
Tan, BH1
Wilson, GL1
Schaffer, SW1
Wako, Y1
Kimura, S1
Kakemi, M1
Sasaki, H2
Saeki, K1
Endoh, M1
Katayama, K1
Koizumi, T1
Kelleher, DL1
Bagby, GJ1
Fong, BC1
Spitzer, JJ1
Hetenyi, G1
Kojima, H1
Kutchai, H1
Grantham, JR1
Geddis, LM1
Dalstein, JM1
Ribes, G1
Campo, P1
Loubatières-Mariani, MM1
Lloyd, P1
Smith, SA1
Stribling, D1
Pogson, CI1
Winegrad, AI1
Andrade, J1
Conde, M2
Sobrino, F2
Bedoya, FJ1
Manuel Keenoy, B1
Maggetto, C1
Henly, DC1
Phillips, JW1
Berry, MN1
Yamatani, K2
Marubashi, S1
Wakasugi, K1
Saito, K2
Sato, N1
Takahashi, K1
Moir, AM1
Zammit, VA1
Khandoudi, N2
Bernard, M1
Cozzone, P1
Feuvray, D1
Tilton, RG1
Chang, K1
Nyengaard, JR1
Van den Enden, M1
Ido, Y1
Williamson, JR1
Miles, PD1
Brown, MR1
Lickley, HL2
Vranic, M2
Shimabukuro, M1
Nagamine, F1
Murakami, K1
Oshiro, K1
Mimura, G1
Geisen, K1
Utz, R1
Grötsch, H1
Lang, HJ2
Nimmesgern, H1
Thompson, CS1
Strong, P1
Mikhailidis, DP1
Kondoh, Y2
Kawase, M2
Hirata, M1
Ohmori, S3
Moley, KH1
Vaughn, WK1
Diamond, MP1
Jawerbaum, A1
Gonzalez, ET1
Catafau, JR1
Rodriguez, RR1
Gomez, G1
Gimeno, AL1
Gimeno, MA1
Higuchi, M3
Uezu, K1
Sakanashi, M3
Yamakawa, I2
Watanabe, S2
Matsuno, Y1
Kuzuya, M1
Hotta, N1
Komori, T1
Kobayashi, M1
Sakakibara, F1
Koh, N1
Sakamoto, N1
Moreno-Aurioles, VR1
Montaño, R1
Bustos, R1
Tormo, MA1
Gómez-Zubeldia, MA1
Ropero, F1
Muñoz-Casillas, M1
Moreno, JC1
Campillo, JE1
Miyagi, K1
Nakasone, J1
Lanier, WL1
Hofer, RE1
Gallagher, WJ1
Young, AA1
Wang, MW1
Gedulin, B1
Rink, TJ1
Pittner, R1
Beaumont, K1
Strödter, D1
Overbeck, A1
Syed Ali, S1
Seitz, S1
Bretzel, RG1
Federlin, K1
Stanley, WC1
Hall, JL1
Hacker, TA1
Hernandez, LA1
Whitesell, LF1
Fischer, Y1
Böttcher, U1
Eblenkamp, M1
Thomas, J1
Jüngling, E1
Rösen, P1
Kammermeier, H1
Ferraz, M1
Brunaldi, K1
Oliveira, CE1
Bazotte, RB2
Khamaisi, M1
Potashnik, R1
Tirosh, A1
Demshchak, E1
Rudich, A1
Tritschler, H1
Wessel, K1
Bashan, N1
Tatsumi, T1
Matoba, S1
Kobara, M1
Keira, N1
Kawahara, A1
Tsuruyama, K1
Tanaka, T1
Katamura, M1
Nakagawa, C1
Ohta, B1
Yamahara, Y1
Asayama, J1
Nakagawa, M1
Vilchis, C1
Hernández-Muñoz, R1
Oshida, Y1
Sato, J1
Nakai, N1
Shimomura, Y1
Ohsawa, I1
Sato, Y1
Mohan, IK1
Large, V1
Beylot, M1
Chatham, JC1
Gao, ZP1
Forder, JR1
Waring, JV1
Wendt, IR1
Hoshino, T1
Muranishi, H1
Notoya, K1
Makino, H1
Nagai, H1
Sohda, T1
Guyot, LL2
Diaz, FG2
O'Regan, MH2
Song, D2
Phillis, JW2
Ladrière, L1
Ravingerova, T2
Stetka, R2
Volkovova, K2
Pancza, D1
Dzurba, A1
Ziegelhöffer, A2
Styk, J2
Hajduch, E1
Heyes, RR1
Watt, PW1
Hundal, HS1
Oku, A2
Ueta, K2
Arakawa, K2
Kano-Ishihara, T2
Matsumoto, T1
Adachi, T1
Yasuda, K1
Tsuda, K1
Ikezawa, K1
Saito, A2
Kondo, Y1
Nakatani, A1
Hayashi, K1
Ito, M1
Nawano, M1
Fujita, T1
Umebayashi, I1
Anai, M1
Funaki, M1
Kikuchi, M1
Oka, Y1
Asano, T1
Obrosova, IG1
Stevens, MJ1
Py, G2
Eydoux, N2
Perez-Martin, A1
Raynaud, E1
Brun, JF1
Préfaut, C2
Mercier, J2
Neckar, J1
Kolar, F1
Akimoto, LS1
Pedrinho, SR1
Lopes, G1
Fukushima, T1
Korenaga, T1
Ichihara, H1
Kato, M1
Imai, K1
Lapidot, A1
Haber, S1
Delerive, P1
Berrebi-Bertrand, I1
Buckingham, RE1
Staels, B1
Bril, A1
Lambert, K1
Milhavet, O1
Svensson, AM1
Borg, LA1
Eriksson, UJ1
Lopaschuk, GD1
Saddik, M1
Barr, R1
Barker, CC1
Muzyka, RA1
Ikema, S1
Kawakami, Y1
Foot, E1
Bliss, T1
Da Costa, C1
Leighton, B1
Folbergrová, J1
Memezawa, H1
Smith, ML1
Siesjö, BK1
Wu, GY2
Field, CJ3
Marliss, EB3
Chayoth, R1
Montambault, M1
Grabowska-Maślanka, H1
Bryniarski, K1
Karl, IE1
Gavin, JR1
Kawahara, M1
Miyake, Y1
Wasserman, DH1
Fujiwara, T1
Yoshioka, S1
Yoshioka, T1
Ushiyama, I1
Horikoshi, H1
Kosugi, K1
Scofield, RF1
Chandramouli, V1
Kumaran, K1
Schumann, WC1
Landau, BR1
Niewoehner, CB1
Nuttall, FQ1
Johnston, DG1
Johnson, GA1
Millward-Sadler, GH1
Mitchell, J1
Wright, R1
Agarwal, VR1
Rastogi, AK1
Sagar, P1
Iwamoto, T1
Low, PA2
Schmelzer, JD2
Ward, KK1
Curran, GL1
Poduslo, JF1
Albisser, AM1
Nomura, M1
McPhedran, NT1
Smith, DM1
Fuller, SJ1
Sugden, PH1
Kilgour, RD1
Riggs, CE1
Kleckner, NW1
Kizaki, Z1
Thurman, RG1
Herrera, E2
Palacin, M2
Martin, A2
Lasuncion, MA2
Chitra, CI1
Cuezva, JM2
Patel, MS2
Koh, ET1
Mueller, J1
Osilesi, O1
Knehans, A1
Reiser, S1
Cirkel, U1
Burkart, W1
Stähler, E1
Buchholz, R1
Ward, K1
Brimijoin, S1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults[NCT03520569]Early Phase 115 participants (Actual)Interventional2019-02-04Completed
Determining the Factors That Affects Emergency Department Visits of Hyperglycemic Patients in 30 Days.[NCT04665128]120 participants (Anticipated)Observational2020-12-15Recruiting
Phase 1 Study To Determine the Effects of Short Term Near-infrared Light (NIR) Therapy on Anatomic and Functional Abnormalities of Diabetic Macular Edema, and Assess Safety of Short Term Near-infrared Light Therapy in Eyes With Diabetic Macular Edema.[NCT00846092]Phase 14 participants (Actual)Interventional2007-11-30Completed
A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment: Bergman's Minimal Model Analysis[NCT00337350]Phase 420 participants (Actual)Interventional2003-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Augmentation Index Between Baseline and After 2 Hour Insulin Clamp

The augmentation index (AIx) measured at the radial artery is a measure of systemic arterial stiffness, and is defined as the ratio of augmentation (Δ P) to central pulse pressure and expressed as percent. AIx = (ΔP/PP) x 100, where P = pressure and PP = Pulse Pressure. Higher percentages indicate increased arterial stiffness. (NCT03520569)
Timeframe: baseline and after 2 hour insulin clamp

Interventionpercentage (Mean)
Octreotide- Euglycemia-4.15
Octreotide - Euglycemia- Insulin Clamp-2.23
Octreotide- Hyperglycemia-4.80
Octreotide- Hyperglycemia - Insulin Clamp-8.45

Change in Flow Mediated Dilation (FMD) Between Baseline and After 2 Hour Insulin Clamp

Flow mediated dilation measures the change in brachial diameter in response to 5 minutes of ischemia using B-mode ultrasound. It provides an index of nitric oxide generation by the endothelium . (NCT03520569)
Timeframe: baseline and after 2 hour insulin clamp

Intervention% change (Mean)
Octreotide- Euglycemia11.8
Octreotide - Euglycemia- Insulin Clamp11.8
Octreotide- Hyperglycemia8.9
Octreotide- Hyperglycemia - Insulin Clamp8.95

Change in Pulse Wave Velocity (PWV) Between Baseline and After 2 Hour Insulin Clamp

The time required for a blood pressure wave to travel from the carotid to the femoral artery was measured in meter/sec. This is a measurement of central artery stiffness. Higher numbers indicate stiffer vessels (NCT03520569)
Timeframe: baseline and after 2 hour insulin clamp

Interventionm/sec (Mean)
Octreotide- Euglycemia5.21
Octreotide - Euglycemia- Insulin Clamp5.06
Octreotide- Hyperglycemia4.79
Octreotide- Hyperglycemia - Insulin Clamp5.07

Change From Baseline in Acute Insulin Response to Glucose (AIRG)

Acute insulin response to glucose (AIRG) was assessed using a Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT), performed at Baseline and at week 8 (study endpoint). Subjects in the Rosiglitazone treatment arm were compared to subjects in the placebo treatment arm on their change in SG between Baseline and week 8. AIRG was calculated from plasma glucose and serum insulin values using the MINMOD Millennium computer program. AIRG measures the acute(0-10 min) beta cell response to a glucose load calculated by the areas under the curve higher than basal insulin values. The AIRG was assessed as the incremental area under the curve (calculated by the trapezoid rule) from 0 to 10 min of the FSIVGTT. (NCT00337350)
Timeframe: baseline, week 8

InterventionUnits/mL per 10 minutes (Mean)
Rosiglitazone-151
Placebo19

Change From Baseline in Insulin Sensitivity

Insulin Sensitivity (IS) was assessed using a Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT), performed at Baseline and at week 8 (study endpoint). Subjects in the Rosiglitazone treatment arm were compared to subjects in the placebo treatment arm on their change in IS between Baseline and week 8. SI was calculated from plasma glucose and serum insulin values using the MINMOD Millennium computer program. SI represents the increase in net fractional glucose clearance rate per unit change in serum insulin concentration after the intravenous glucose load (microUnits/mL). (NCT00337350)
Timeframe: baseline, week 8

InterventionmicroUnits/mL (Mean)
Rosiglitazone3.2
Placebo0.4

Change From Baseline on Glucose Utilization (SG)

Glucose utilization (SG) was assessed using a Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT), performed at Baseline and at week 8 (study endpoint). Subjects in the Rosiglitazone treatment arm were compared to subjects in the placebo treatment arm on their change in SG between Baseline and week 8. SG was calculated from plasma glucose and serum insulin values using the MINMOD Millennium computer program. SG represents the net fractional glucose clearance rate because of the increase in glucose independent of any increase in circulating insulin concentrations above baseline. (NCT00337350)
Timeframe: baseline, week 8

Interventionmin^-1 (Mean)
Rosiglitazone.002
Placebo-0.01

Reviews

1 review available for lactic acid and Alloxan Diabetes

ArticleYear
Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes.
    Drug discovery today, 2023, Volume: 28, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Carriers; Humans; Insulin;

2023

Other Studies

247 other studies available for lactic acid and Alloxan Diabetes

ArticleYear
A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:6

    Topics: Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Diabetes Mellitus, Experimental; Disea

2022
Cadmium exposure decreases fasting blood glucose levels and exacerbates type-2 diabetes in a mouse model.
    Endocrine, 2022, Volume: 76, Issue:1

    Topics: Animals; Blood Glucose; Cadmium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease

2022
Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
    International journal of biological macromolecules, 2022, Jun-01, Volume: 209, Issue:Pt B

    Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Glycols; Gold; Insulin; Lactic Ac

2022
Effects of Fibroblast Growth Factor 21 on Lactate Uptake and Usage in Mice with Diabetes-Associated Cognitive Decline.
    Molecular neurobiology, 2022, Volume: 59, Issue:9

    Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Fibroblast Growth Factors; Humans;

2022
Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease.
    Cell metabolism, 2023, 01-03, Volume: 35, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Lactic Acid; Mammals; Mice; Mitochondria

2023
Hyperpolarized [1-
    Yonsei medical journal, 2023, Volume: 64, Issue:10

    Topics: Agmatine; Animals; Brain; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Lactic Acid; M

2023
Protective role of adiponectin against testicular impairment in high-fat diet/streptozotocin-induced type 2 diabetic mice.
    Biochimie, 2020, Volume: 168

    Topics: Adiponectin; Animals; Antioxidants; Diabetes Mellitus, Experimental; Glucose; Glucose Transport Prot

2020
Malaysian propolis and metformin mitigate subfertility in streptozotocin-induced diabetic male rats by targeting steroidogenesis, testicular lactate transport, spermatogenesis and mating behaviour.
    Andrology, 2020, Volume: 8, Issue:3

    Topics: Animals; Diabetes Mellitus, Experimental; Fertility; Infertility, Male; Lactic Acid; Male; Metformin

2020
Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy.
    Journal of molecular medicine (Berlin, Germany), 2020, Volume: 98, Issue:2

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Blood Pressure; Cells, Cultured; Dia

2020
Lactate accelerates vascular calcification through NR4A1-regulated mitochondrial fission and BNIP3-related mitophagy.
    Apoptosis : an international journal on programmed cell death, 2020, Volume: 25, Issue:5-6

    Topics: Animals; Aorta; Bone Morphogenetic Protein 2; Cholecalciferol; Core Binding Factor Alpha 1 Subunit;

2020
Citrus fruit-derived flavonoid naringenin and the expression of hepatic organic cation transporter 1 protein in diabetic rats treated with metformin.
    Basic & clinical pharmacology & toxicology, 2020, Volume: 127, Issue:3

    Topics: Animals; Blood Glucose; Citrus; Diabetes Mellitus, Experimental; Flavanones; Flavonoids; Hypoglycemi

2020
Reducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy.
    Experimental neurology, 2020, Volume: 333

    Topics: Animals; Axons; Behavior, Animal; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diabetic

2020
Satellite glia as a critical component of diabetic neuropathy: Role of lipocalin-2 and pyruvate dehydrogenase kinase-2 axis in the dorsal root ganglion.
    Glia, 2021, Volume: 69, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Inflammation; Lact

2021
Increase in brain l-lactate enhances fear memory in diabetic mice: Involvement of glutamate neurons.
    Brain research, 2021, 09-15, Volume: 1767

    Topics: Amygdala; Animals; Anxiety; Brain; Diabetes Mellitus, Experimental; Excitatory Amino Acid Antagonist

2021
Hyperbaric oxygen therapy reduces renal lactate production.
    Physiological reports, 2017, Volume: 5, Issue:6

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Hyperbaric Oxygenation; Ki

2017
Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin.
    Materials science & engineering. C, Materials for biological applications, 2017, Sep-01, Volume: 78

    Topics: Administration, Oral; Animals; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Insulin; La

2017
Decreased expression of orexin 1 receptor in adult mice testes during alloxan-induced diabetes mellitus perturbs testicular steroidogenesis and glucose homeostasis.
    Biochemical and biophysical research communications, 2017, 09-02, Volume: 490, Issue:4

    Topics: Alloxan; Animals; Apoptosis; Body Weight; Caspase 3; Diabetes Mellitus, Experimental; Gene Expressio

2017
Oxamate Enhances the Anti-Inflammatory and Insulin-Sensitizing Effects of Metformin in Diabetic Mice.
    Pharmacology, 2017, Volume: 100, Issue:5-6

    Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabet

2017
Construction of functional pancreatic artificial islet tissue composed of fibroblast-modified polylactic- co-glycolic acid membrane and pancreatic stem cells.
    Journal of biomaterials applications, 2017, Volume: 32, Issue:3

    Topics: Animals; Biocompatible Materials; Cell Differentiation; Diabetes Mellitus, Experimental; Islets of L

2017
Microspheres for the oral delivery of insulin: preparation, evaluation and hypoglycaemic effect in streptozotocin-induced diabetic rats.
    Drug development and industrial pharmacy, 2018, Volume: 44, Issue:1

    Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Lactic

2018
Insulin-loaded PLGA microspheres for glucose-responsive release.
    Drug delivery, 2017, Volume: 24, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Insulin; Lactic Acid; Mice; Microspheres; Particl

2017
Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Alkaline Phosphatase; Animals; Antagomirs; Bone and Bones; Cell Adhesion; Cell Death; Cell Survival;

2017
Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide.
    Colloids and surfaces. B, Biointerfaces, 2018, Jan-01, Volume: 161

    Topics: Administration, Oral; Animals; Blood Glucose; Cell Survival; Chitosan; Diabetes Mellitus, Experiment

2018
Tissue adhesive FK506-loaded polymeric nanoparticles for multi-layered nano-shielding of pancreatic islets to enhance xenograft survival in a diabetic mouse model.
    Biomaterials, 2018, Volume: 154

    Topics: Animals; Coated Materials, Biocompatible; Collagen; Diabetes Mellitus, Experimental; Dihydroxyphenyl

2018
Single-Droplet Multiplex Bioassay on a Robust and Stretchable Extreme Wetting Substrate through Vacuum-Based Droplet Manipulation.
    ACS nano, 2018, 02-27, Volume: 12, Issue:2

    Topics: Animals; Biological Assay; Colorimetry; Diabetes Mellitus, Experimental; Dimethylpolysiloxanes; Gluc

2018
Non-invasive detection of divergent metabolic signals in insulin deficiency vs. insulin resistance in vivo.
    Scientific reports, 2018, 02-01, Volume: 8, Issue:1

    Topics: Alanine; Animals; Diabetes Mellitus, Experimental; Gluconeogenesis; Insulin; Insulin Resistance; Kid

2018
Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    International journal of pharmaceutics, 2018, May-05, Volume: 542, Issue:1-2

    Topics: Animals; Biological Availability; Blood Glucose; Cell Line; Cell Survival; Coculture Techniques; Dia

2018
Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.
    Neuropharmacology, 2018, Volume: 135

    Topics: Acidosis; Acrylamides; Animals; Brain Ischemia; CA1 Region, Hippocampal; Central Nervous System Agen

2018
Balanites aegyptiaca ameliorates insulin secretion and decreases pancreatic apoptosis in diabetic rats: Role of SAPK/JNK pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 102

    Topics: Animals; Apoptosis; Balanites; Blood Glucose; Chromatography, Liquid; Diabetes Mellitus, Experimenta

2018
Effect of photobiomodulation therapy on oxidative stress markers of gastrocnemius muscle of diabetic rats subjected to high-intensity exercise.
    Lasers in medical science, 2018, Volume: 33, Issue:8

    Topics: Animals; Biomarkers; Catalase; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Lactic Acid;

2018
Metabolomic Analysis Identifies Lactate as an Important Pathogenic Factor in Diabetes-associated Cognitive Decline Rats.
    Molecular & cellular proteomics : MCP, 2018, Volume: 17, Issue:12

    Topics: Analysis of Variance; Animals; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; C

2018
Targeted folate-conjugated pluronic P85/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:19

    Topics: Administration, Oral; Animals; Caco-2 Cells; Cell Proliferation; Diabetes Mellitus, Experimental; Fl

2018
Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:3

    Topics: Adenosine Triphosphate; Administration, Intranasal; Animals; Brain; Coumaric Acids; Dementia; Diabet

2019
Inhibiting hepatic gluconeogenesis by chitosan lactate nanoparticles containing CRTC2 siRNA targeted by poly(ethylene glycol)-glycyrrhetinic acid.
    Drug delivery and translational research, 2019, Volume: 9, Issue:3

    Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Gene Expression; Gluconeogenesis; Glycyrrhetinic

2019
Metformin mitigates impaired testicular lactate transport/utilisation and improves sexual behaviour in streptozotocin-induced diabetic rats.
    Archives of physiology and biochemistry, 2021, Volume: 127, Issue:1

    Topics: Animals; Biological Transport; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose T

2021
High Intrarenal Lactate Production Inhibits the Renal Pseudohypoxic Response to Acutely Induced Hypoxia in Diabetes.
    Tomography (Ann Arbor, Mich.), 2019, Volume: 5, Issue:2

    Topics: Acute Disease; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hypoxia; Ki

2019
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals.
    Cell death & disease, 2013, May-02, Volume: 4

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognition Disorders; Diabetes Mellitus, Ex

2013
25-Hydroxyvitamin D(3)-loaded PLA microspheres: in vitro characterization and application in diabetic periodontitis models.
    AAPS PharmSciTech, 2013, Volume: 14, Issue:2

    Topics: Alveolar Bone Loss; Animals; Calcifediol; Cell Survival; Cells, Cultured; Chemistry, Pharmaceutical;

2013
Dysfunction of membrane-receptor system of blood cells and kidney tissue in experimental diabetes mellitus.
    Bulletin of experimental biology and medicine, 2013, Volume: 154, Issue:5

    Topics: Acidosis, Lactic; Adenosine Triphosphate; Animals; Blood Glucose; Cell Membrane; Diabetes Mellitus,

2013
Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug.
    Biomaterials, 2013, Volume: 34, Issue:23

    Topics: Animals; Anti-Inflammatory Agents; Capsules; Cathepsins; Diabetes Mellitus, Experimental; Fibrosis;

2013
Insulin concentrations in cerebellum and body balance in diabetic male rats: aerobic training effects.
    Physiology & behavior, 2013, Jun-13, Volume: 118

    Topics: Aerobiosis; Analysis of Variance; Animals; Blood Glucose; Cerebellum; Conditioning, Psychological; D

2013
rhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Nov-20, Volume: 50, Issue:3-4

    Topics: 3T3 Cells; Alginates; Animals; Cell Movement; Cell Proliferation; Diabetes Mellitus, Experimental; E

2013
Lactate-induced release of GABA in the ventromedial hypothalamus contributes to counterregulatory failure in recurrent hypoglycemia and diabetes.
    Diabetes, 2013, Volume: 62, Issue:12

    Topics: Animals; Bicuculline; Coumaric Acids; Diabetes Mellitus, Experimental; Diazoxide; GABA Antagonists;

2013
Standardization of resistance exercise training: effects in diabetic ovariectomized rats.
    International journal of sports medicine, 2014, Volume: 35, Issue:4

    Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Female; Fructo

2014
Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Aldehyde Reductase; Animals; Antioxidants; Biocompatible Materials; Biodegradation, Environmental; B

2013
Ultrasound-triggered regulation of blood glucose levels using injectable nano-network.
    Advanced healthcare materials, 2014, Volume: 3, Issue:6

    Topics: Alginates; Animals; Blood Glucose; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Glucuro

2014
Lactate and the mechanism of hypoglycemia-associated autonomic failure in diabetes.
    Diabetes, 2013, Volume: 62, Issue:12

    Topics: Animals; Diabetes Mellitus, Experimental; gamma-Aminobutyric Acid; Hypoglycemia; Lactic Acid; Male;

2013
Endurance training increases brain lactate uptake during hypoglycemia by up regulation of brain lactate transporters.
    Molecular and cellular endocrinology, 2014, Aug-25, Volume: 394, Issue:1-2

    Topics: Animals; Biological Transport; Cerebral Cortex; Diabetes Mellitus, Experimental; Gene Expression; Hi

2014
Fabrication and structure analysis of poly(lactide-co-glycolic acid)/silk fibroin hybrid scaffold for wound dressing applications.
    International journal of pharmaceutics, 2014, Oct-01, Volume: 473, Issue:1-2

    Topics: Animals; Bandages; Cell Line; Diabetes Mellitus, Experimental; Fibroblasts; Fibroins; Lactic Acid; M

2014
The effect of high-fat diet and streptozotocin-induced diabetes and endurance training on plasma levels of calcitonin gene-related peptide and lactate in rats.
    Canadian journal of diabetes, 2014, Volume: 38, Issue:6

    Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diet, High-Fat; Lactic Ac

2014
Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity.
    Microbiology (Reading, England), 2015, Volume: 161, Issue:Pt 1

    Topics: Animals; Antibiotics, Antineoplastic; Biodiversity; Diabetes Mellitus, Experimental; Diabetes Mellit

2015
Augmentation of diabetic wound healing and enhancement of collagen content using nanofibrous glucophage-loaded collagen/PLGA scaffold membranes.
    Journal of colloid and interface science, 2015, Feb-01, Volume: 439

    Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Drug Administration Routes; Hypoglycemic Agents;

2015
Attenuation of inflammatory response by 25- hydroxyvitamin D3-loaded polylactic acid microspheres in treatment of periodontitis in diabetic rats.
    The Chinese journal of dental research, 2014, Volume: 17, Issue:2

    Topics: Administration, Topical; Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Animals; Anti-In

2014
Molecular mechanism of poly(vinyl alcohol) mediated prevention of aggregation and stabilization of insulin in nanoparticles.
    Molecular pharmaceutics, 2015, Apr-06, Volume: 12, Issue:4

    Topics: Acrylamides; Animals; Calorimetry, Differential Scanning; Cattle; Chlorides; Circular Dichroism; Dia

2015
Intrauterine Growth Restricted Rats Exercised at Pregnancy: Maternal-Fetal Repercussions.
    Reproductive sciences (Thousand Oaks, Calif.), 2015, Volume: 22, Issue:8

    Topics: Acidosis, Lactic; Animals; Biomarkers; Birth Weight; Blood Glucose; Diabetes Mellitus, Experimental;

2015
Novel PLGA-based nanoparticles for the oral delivery of insulin.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Administration, Oral; alpha-Tocopherol; Animals; Diabetes Mellitus, Experimental; Drug Carriers; Emu

2015
Exendin-4-loaded PLGA microspheres relieve cerebral ischemia/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt/eNOS signaling in rats.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015, Volume: 35, Issue:11

    Topics: Animals; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cerebrovascular Circulation; Cognition

2015
N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    ACS applied materials & interfaces, 2015, Jul-22, Volume: 7, Issue:28

    Topics: Administration, Oral; Animals; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delive

2015
Promoting Diabetic Wound Therapy Using Biodegradable rhPDGF-Loaded Nanofibrous Membranes: CONSORT-Compliant Article.
    Medicine, 2015, Volume: 94, Issue:47

    Topics: Absorbable Implants; Animals; Becaplermin; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorb

2015
Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy.
    The Journal of biological chemistry, 2016, Mar-11, Volume: 291, Issue:11

    Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; G

2016
Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, Apr-10, Volume: 227

    Topics: Administration, Oral; Animals; Blood Glucose; Dextrans; Diabetes Mellitus, Experimental; Dogs; Drug

2016
Improvement of islet engrafts by enhanced angiogenesis and microparticle-mediated oxygenation.
    Biomaterials, 2016, Volume: 89

    Topics: Animals; Blood Glucose; Catalase; Cell Hypoxia; Cell Line; Diabetes Mellitus, Experimental; Enzymes,

2016
Preparation and Evaluations of Mangiferin-Loaded PLGA Scaffolds for Alveolar Bone Repair Treatment Under the Diabetic Condition.
    AAPS PharmSciTech, 2017, Volume: 18, Issue:2

    Topics: Alveolar Bone Loss; Animals; Bone Regeneration; Delayed-Action Preparations; Diabetes Mellitus, Expe

2017
Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 07-10, Volume: 233

    Topics: Adhesiveness; Administration, Oral; Animals; Blood Glucose; Cell Line, Tumor; Cell-Penetrating Pepti

2016
Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016, Sep-20, Volume: 92

    Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Melli

2016
Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.
    American journal of physiology. Endocrinology and metabolism, 2016, 08-01, Volume: 311, Issue:2

    Topics: Amino Acids, Branched-Chain; Animals; Bile Acids and Salts; Case-Control Studies; Citric Acid Cycle;

2016
Effects of Pluronic F127-PEG multi-gel-core on the release profile and pharmacodynamics of Exenatide loaded in PLGA microspheres.
    Colloids and surfaces. B, Biointerfaces, 2016, Nov-01, Volume: 147

    Topics: Animals; Biocompatible Materials; Diabetes Mellitus, Experimental; Drug Delivery Systems; Drug Liber

2016
Metabolic effects of basic fibroblast growth factor in streptozotocin-induced diabetic rats: A
    Scientific reports, 2016, 11-03, Volume: 6

    Topics: Amino Acids; Animals; Blood Glucose; Choline; Citric Acid; Diabetes Mellitus, Experimental; Discrimi

2016
Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
    International journal of biological macromolecules, 2017, Volume: 95

    Topics: Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding;

2017
Multifunctional Composite Microcapsules for Oral Delivery of Insulin.
    International journal of molecular sciences, 2016, Dec-28, Volume: 18, Issue:1

    Topics: Administration, Oral; Animals; Capsules; Diabetes Mellitus, Experimental; Drug Liberation; Insulin;

2016
Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.
    Advanced healthcare materials, 2017, Volume: 6, Issue:6

    Topics: Animals; Antigens; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydrogels; Immune Tol

2017
Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
    Pharmaceutical development and technology, 2018, Volume: 23, Issue:4

    Topics: Animals; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Emulsions; Hypoglycemic Agent

2018
Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes.
    The Journal of endocrinology, 2008, Volume: 199, Issue:3

    Topics: Adipocytes; Adipokines; Animals; Animals, Newborn; Cells, Cultured; Culture Media, Conditioned; Diab

2008
Evaluation of parenteral depot insulin formulation using PLGA and PLA microparticles.
    Journal of biomaterials applications, 2009, Volume: 24, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Female; Humans; Hypo

2009
Repair effect of diabetic ulcers with recombinant human epidermal growth factor loaded by sustained-release microspheres.
    Science in China. Series C, Life sciences, 2008, Volume: 51, Issue:11

    Topics: Animals; Biocompatible Materials; Cell Line; Cell Proliferation; Delayed-Action Preparations; Diabet

2008
The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cells.
    Biomaterials, 2009, Volume: 30, Issue:9

    Topics: Animals; Biomarkers; Blood Glucose; Cell Differentiation; Cell Shape; Diabetes Mellitus, Experimenta

2009
Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Journal of controlled release : official journal of the Controlled Release Society, 2009, Apr-02, Volume: 135, Issue:1

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Inhalation; Aerosols; Animals; beta-Cyclodextrins

2009
Effects of exercise training on hippocampus concentrations of insulin and IGF-1 in diabetic rats.
    Hippocampus, 2009, Volume: 19, Issue:10

    Topics: Analysis of Variance; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Exercise Test; Glycog

2009
A novel DPP-IV-resistant analog of glucagon-like peptide-1 (GLP-1): KGLP-1 alone or in combination with long-acting PLGA microspheres.
    Peptides, 2009, Volume: 30, Issue:10

    Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Drug Compounding; Femal

2009
Effects of poly (lactic-co-glycolic acid) as a co-emulsifier on the preparation and hypoglycaemic activity of insulin-loaded solid lipid nanoparticles.
    IET nanobiotechnology, 2009, Volume: 3, Issue:4

    Topics: Analysis of Variance; Animals; Blood Glucose; Castor Oil; Chemical Phenomena; Diabetes Mellitus, Exp

2009
Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Journal of microencapsulation, 2010, Volume: 27, Issue:6

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents

2010
Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
    Biopharmaceutics & drug disposition, 2010, Volume: 31, Issue:2-3

    Topics: Administration, Inhalation; Animals; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Drug

2010
[Effect of sustained release of recombinant rat insulin-like growth factor-1 from poly (lactide-CO-glycolide ) microspheres on bone formation in the peri-implant areas in Goto-Kakizaki rats with type 2 diabetes].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2010, Volume: 32, Issue:3

    Topics: Animals; Delayed-Action Preparations; Dental Implants; Diabetes Mellitus, Experimental; Diabetes Mel

2010
Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
    Die Pharmazie, 2010, Volume: 65, Issue:6

    Topics: Algorithms; Androstadienes; Animals; Cell Line; Cell Survival; Delayed-Action Preparations; Diabetes

2010
Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
    Journal of diabetes, 2009, Volume: 1, Issue:1

    Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Chemistry, Pharmaceutical; Delayed-Action

2009
Exercise test and glucose homeostasis in rats treated with alloxan during the neonatal period or fed a high calorie diet.
    Journal of diabetes, 2009, Volume: 1, Issue:1

    Topics: Age Factors; Aging; Animals; Animals, Newborn; Biomarkers; Blood Glucose; Diabetes Mellitus, Experim

2009
Evaluation of the impact of diabetes on retinal metabolites by NMR spectroscopy.
    Current eye research, 2010, Volume: 35, Issue:11

    Topics: Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucose

2010
Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
    Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:11

    Topics: Animals; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Exenatide; Hypoglycemic Agent

2010
Determination of time-dependent accumulation of D-lactate in the streptozotocin-induced diabetic rat kidney by column-switching HPLC with fluorescence detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Nov-01, Volume: 879, Issue:29

    Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Histocyt

2011
Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:3

    Topics: Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetic Neuropathie

2011
[Comparative characteristic of energy supply disturbances in arterial and venous walls of rabbits with alloxan diabetes and monoiodacetate intoxication].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2011, Volume: 57, Issue:2

    Topics: Adenosine Triphosphate; Alloxan; Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Energy M

2011
FTY720-loaded poly(DL-lactide-co-glycolide) electrospun scaffold significantly increases microvessel density over 7 days in streptozotocin-induced diabetic C57b16/J mice: preliminary results.
    Transplantation proceedings, 2011, Volume: 43, Issue:9

    Topics: Animals; Automation; Biocompatible Materials; Diabetes Mellitus, Experimental; Drug Delivery Systems

2011
Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:4

    Topics: Administration, Oral; Animals; Biocompatible Materials; Blood Glucose; Diabetes Mellitus, Experiment

2012
Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.
    International journal of pharmaceutics, 2013, Jan-02, Volume: 440, Issue:1

    Topics: Administration, Oral; Animals; Antacids; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemi

2013
HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    International journal of pharmaceutics, 2012, Apr-04, Volume: 425, Issue:1-2

    Topics: Acrylic Resins; Administration, Oral; Animals; Blood Glucose; Capsules; Diabetes Mellitus, Experimen

2012
Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism.
    Diabetes, 2012, Volume: 61, Issue:7

    Topics: Adenosine Triphosphate; Animals; Aspartic Acid; Brain Edema; Cerebrum; Diabetes Mellitus, Experiment

2012
Effect of zinc supplementation on lipid peroxidation and lactate levels in rats with diabetes induced by streptozotocin and subjected to acute swimming exercise.
    Bratislavske lekarske listy, 2012, Volume: 113, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Lactic Acid; Lipid Peroxidation; Male; Physical Exertion;

2012
Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Nanomedicine (London, England), 2012, Volume: 7, Issue:9

    Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Carriers; Folic

2012
Sustained topical delivery of insulin from fibrin gel loaded with poly(lactic-co-glycolic Acid) microspheres improves the biomechanical retention of titanium implants in type 1 diabetic rats.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:10

    Topics: Administration, Topical; Animals; Biomechanical Phenomena; Delayed-Action Preparations; Dental Impla

2012
Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2012, Volume: 114, Issue:3

    Topics: Animals; Biocompatible Materials; Dental Implants; Dental Materials; Diabetes Mellitus, Experimental

2012
In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    International journal of pharmaceutics, 2012, Nov-01, Volume: 437, Issue:1-2

    Topics: Animals; Blood Glucose; Caco-2 Cells; Diabetes Mellitus, Experimental; Drug Carriers; Endocytosis; H

2012
Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere.
    Biomaterials, 2012, Volume: 33, Issue:34

    Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Histidine; Hyp

2012
The use of native chemical functional groups presented by wound beds for the covalent attachment of polymeric microcarriers of bioactive factors.
    Biomaterials, 2013, Volume: 34, Issue:2

    Topics: Animals; Catechols; Dermis; Diabetes Mellitus, Experimental; Drug Carriers; Lactic Acid; Male; Malei

2013
A syndrome of severe hypoglycemia and acidosis in young immunosuppressed diabetic monkeys and pigs-association with sepsis.
    Transplantation, 2012, Dec-27, Volume: 94, Issue:12

    Topics: Acidosis; Animals; Bacteria; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal;

2012
Assessment of early diabetic renal changes with hyperpolarized [1-(13) C]pyruvate.
    Diabetes/metabolism research and reviews, 2013, Volume: 29, Issue:2

    Topics: Animals; Bicarbonates; Carbon Isotopes; Diabetes Mellitus, Experimental; Female; Kidney; L-Lactate D

2013
Polymeric "smart" coatings to prevent foreign body response to implantable biosensors.
    Journal of controlled release : official journal of the Controlled Release Society, 2013, Aug-10, Volume: 169, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Biosensing Techniques; Blood Glucose; Coated Materials, Biocompat

2013
Haemodynamic and metabolic effects of low daily dose sulphonylureas in diabetic dog hearts.
    Arzneimittel-Forschung, 2002, Volume: 52, Issue:7

    Topics: Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Diabetes Mellitus, Experimental; Dogs;

2002
[Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2002, Volume: 37, Issue:5

    Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experiment

2002
Exercise training alleviates MCT1 and MCT4 reductions in heart and skeletal muscles of STZ-induced diabetic rats.
    Journal of applied physiology (Bethesda, Md. : 1985), 2003, Volume: 94, Issue:6

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Lactic Acid; Male; Monocarboxy

2003
Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Pharmaceutical research, 2003, Volume: 20, Issue:3

    Topics: Acrylic Resins; Animals; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Drug Stab

2003
Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin.
    Drug development and industrial pharmacy, 2003, Volume: 29, Issue:5

    Topics: Animals; Area Under Curve; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experiment

2003
Shift in metabolic substrate uptake by the heart during development of alloxan-induced diabetes.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:3

    Topics: 3-Hydroxybutyric Acid; Alloxan; Animals; Blood Glucose; Blood Pressure; Body Weight; Carbon Dioxide;

2003
Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.
    Endocrinology, 2003, Volume: 144, Issue:12

    Topics: Alloxan; Animals; Blood Gas Analysis; Blood Glucose; Body Weight; Burns; Critical Illness; Diabetes

2003
[On the metabolism of injured tissues. 11. Pyridine nucleotide content, lactic acid content, and pyruvic acid content of the liver of normal and alloxan-diabetic mice after glucose and fructose loading].
    Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1960, Aug-31, Volume: 320

    Topics: Alloxan; Animals; Coenzymes; Diabetes Mellitus, Experimental; Fructose; Glucose; Lactates; Lactic Ac

1960
[Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2003, Volume: 38, Issue:6

    Topics: Animals; Blood Glucose; Chitin; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Drug Deliv

2003
Effect of fructose on lipogenesis from lactate and acetate in diabetic liver.
    The Journal of biological chemistry, 1952, Volume: 194, Issue:1

    Topics: Acetates; Animals; Diabetes Mellitus, Experimental; Fatty Acids; Fructose; Lactates; Lactic Acid; Li

1952
The effect of hyperglycemia on experimental retinal ischemia.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:3

    Topics: Animals; Blood Glucose; Cyclophilins; Deoxyglucose; Diabetes Mellitus, Experimental; Electroretinogr

2004
Isotopic discrimination between D-[1-(13)C]fructose and D-[2-(13)C]fructose in rat liver cells.
    Biochimie, 2004, Volume: 86, Issue:2

    Topics: Alanine; Animals; Carbon Isotopes; Cell Separation; Deuterium; Diabetes Mellitus, Experimental; Fruc

2004
Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Pharmaceutical research, 2004, Volume: 21, Issue:2

    Topics: Animals; Biodegradation, Environmental; Diabetes Mellitus, Experimental; Emulsions; Hypoglycemic Age

2004
Optimum formulation for sustained-release insulin.
    International journal of pharmaceutics, 2004, Mar-01, Volume: 271, Issue:1-2

    Topics: Animals; Capsules; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Glycerol; Injection

2004
The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers.
    Endocrine, 2004, Volume: 25, Issue:2

    Topics: Adenosine Triphosphate; Animals; Brain Chemistry; Brain Ischemia; Calcium; Calcium Channel Blockers;

2004
Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    European journal of pharmacology, 2005, Mar-28, Volume: 511, Issue:2-3

    Topics: Aldehydes; Animals; Celecoxib; Conjunctiva; Cyclooxygenase Inhibitors; Delayed-Action Preparations;

2005
PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis.
    Journal of controlled release : official journal of the Controlled Release Society, 2005, Jun-02, Volume: 104, Issue:3

    Topics: Animals; Circular Dichroism; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Glycolate

2005
Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats.
    Molecular and cellular biochemistry, 2005, Volume: 272, Issue:1-2

    Topics: Adaptation, Physiological; Animals; Diabetes Mellitus, Experimental; Fructose; Glucose; Glucose Tran

2005
The effects of peroxovanadate and peroxovanadyl on glucose metabolism in vivo and identification of signal transduction proteins involved in the mechanism of action in isolated soleus muscle.
    Molecular and cellular biochemistry, 2005, Volume: 273, Issue:1-2

    Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Glycogen; Hyperglycemia; Hypoglycemic Agents; Ins

2005
Effect of prostaglandins against alloxan-induced diabetes mellitus.
    Prostaglandins, leukotrienes, and essential fatty acids, 2006, Volume: 74, Issue:1

    Topics: Alloxan; Alprostadil; Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Ceruloplasmin; Di

2006
Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
    Prostaglandins, leukotrienes, and essential fatty acids, 2006, Volume: 74, Issue:3

    Topics: Alloxan; Animals; Arachidonic Acid; Blood Glucose; Body Weight; Catalase; Ceruloplasmin; Diabetes Me

2006
Hypoglycemic activity of jatrorrhizine.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2005, Volume: 25, Issue:5

    Topics: Animals; Berberine; Diabetes Mellitus, Experimental; Glycolysis; Hypoglycemic Agents; L-Lactate Dehy

2005
Glucose metabolism in rat retinal pigment epithelium.
    Neurochemical research, 2006, Volume: 31, Issue:1

    Topics: Animals; Carbon Dioxide; Diabetes Mellitus, Experimental; Female; Glucose; Glycogen; Lactic Acid; Pi

2006
Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:3

    Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Celecoxib; Cell Culture Techniques; Cyclooxy

2006
Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy.
    Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:6

    Topics: Adenosine Triphosphate; Aldehyde Reductase; Animals; Cell Culture Techniques; Diabetes Mellitus, Exp

2006
The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
    Diabetes, 2006, Volume: 55, Issue:6

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Gluc

2006
Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
    American journal of physiology. Endocrinology and metabolism, 2006, Volume: 291, Issue:5

    Topics: Acetyl-CoA Carboxylase; Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide;

2006
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
    Journal of controlled release : official journal of the Controlled Release Society, 2006, Aug-28, Volume: 114, Issue:2

    Topics: Administration, Oral; Algorithms; Animals; Area Under Curve; Biological Availability; Biotransformat

2006
Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Die Pharmazie, 2006, Volume: 61, Issue:7

    Topics: Animals; Blood Glucose; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatograph

2006
[Long-acting injectable microspheres of glucagon-like peptide-1].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2006, Volume: 41, Issue:7

    Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Glucagon-Like

2006
Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:2

    Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Compounding; Dru

2007
Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.
    Journal of materials science. Materials in medicine, 2007, Volume: 18, Issue:11

    Topics: Animals; Coated Materials, Biocompatible; Delayed-Action Preparations; Diabetes Mellitus, Experiment

2007
Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Adiponectin; Animals; bcl-X Protein; Cardiovascular Agents; Coronary Vessels; Diabetes Mellitus, Exp

2007
Na+/H+ exchange inhibition with cariporide prevents alterations of coronary endothelial function in streptozotocin-induced diabetes.
    Molecular and cellular biochemistry, 2008, Volume: 310, Issue:1-2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Glucose; Carbacho

2008
Exercise improves visual deficits tested by visual evoked potentials in streptozotocin-induced diabetic rats.
    The Tohoku journal of experimental medicine, 2007, Volume: 213, Issue:4

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Evoked Potentials, Visual; Eye

2007
Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo.
    Chemical & pharmaceutical bulletin, 2008, Volume: 56, Issue:2

    Topics: Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, E

2008
Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles.
    Journal of microencapsulation, 2008, Volume: 25, Issue:4

    Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experiment

2008
Effects of (-)-(R)-1-(p-hydroxyphenyl)-2-[3,4-dimethoxyphenethyl)amino]ethanol (TA-064), a new cardiotonic agent, on circulating parameters of carbohydrate and lipid metabolism in the rat.
    Biochemical pharmacology, 1984, Jul-15, Volume: 33, Issue:14

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; Cardiotonic Agents; D

1984
Altered biochemical responses by rat Sertoli cells and peritubular cells cultured under simulated diabetic conditions.
    Diabetologia, 1984, Volume: 26, Issue:2

    Topics: 3-Hydroxybutyric Acid; Androgen-Binding Protein; Animals; Bicarbonates; Carrier Proteins; Cells, Cul

1984
Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve.
    The American journal of physiology, 1984, Volume: 246, Issue:4 Pt 1

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Diabetes Mellitus, Experimental; Glucose; Inositol; La

1984
Fetal and neonatal metabolism in the pup of a canine diabetic mother. Fasting circulating fuels and neonatal glucose turnover.
    Diabetes, 1983, Volume: 32, Issue:4

    Topics: Amino Acids; Animals; Animals, Newborn; Diabetes Mellitus, Experimental; Dogs; Fatty Acids, Nonester

1983
Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.
    The American journal of physiology, 1983, Volume: 245, Issue:2

    Topics: 3-Hydroxybutyric Acid; Alanine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Fatty

1983
Glucose metabolism studied isotopically in diabetic dogs: effect of restoration of peripheral normoinsulinaemia by the artificial B cell.
    Diabetologia, 1983, Volume: 25, Issue:5

    Topics: Animals; Blood Glucose; Carbon Radioisotopes; Diabetes Mellitus, Experimental; Dogs; Glucagon; Gluco

1983
Hormonal regulation of glucose transport in contracting skeletal muscle from normal and diabetic rats.
    Metabolism: clinical and experimental, 1984, Volume: 33, Issue:7

    Topics: Animals; Biological Transport; Diabetes Mellitus, Experimental; Electric Stimulation; Epinephrine; G

1984
Regulation of carbohydrate metabolism by 2,5-anhydro-D-mannitol.
    Proceedings of the National Academy of Sciences of the United States of America, 1983, Volume: 80, Issue:14

    Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Fructosediphosphates; Glucagon; G

1983
The effect of ischaemia on the activity of pyruvate dehydrogenase complex in rat heart.
    Journal of molecular and cellular cardiology, 1984, Volume: 16, Issue:8

    Topics: Adenosine Triphosphate; Animals; Coronary Disease; Diabetes Mellitus, Experimental; Dietary Fats; He

1984
Effect of tolbutamide on myocardial metabolism and mechanical performance of the diabetic rat.
    Diabetes, 1984, Volume: 33, Issue:12

    Topics: Animals; Cardiac Output; Diabetes Mellitus, Experimental; Glucose; Heart; Kinetics; Lactates; Lactic

1984
The development of glucose metabolism in infants of diabetic mothers.
    The Tohoku journal of experimental medicine, 1984, Volume: 144, Issue:3

    Topics: Animals; Animals, Newborn; Blood Glucose; Diabetes Mellitus, Experimental; Female; Fetal Blood; Gluc

1984
Pharmacologic effects of metformin in relation to its disposition in alloxan diabetic rats.
    Journal of pharmacobio-dynamics, 1983, Volume: 6, Issue:2

    Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucose Tolerance Tes

1983
Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs.
    Metabolism: clinical and experimental, 1981, Volume: 30, Issue:8

    Topics: 3-Hydroxybutyric Acid; Alanine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Gluca

1981
Glucose turnover five hours following endotoxin administration to normal and diabetic rats.
    Circulatory shock, 1982, Volume: 9, Issue:1

    Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Endotoxins; Escherichia coli; Glucose; Hea

1982
Correction for the metabolic exchange of 14C for 12C atoms in the pathway of gluconeogenesis in vivo.
    Federation proceedings, 1982, Volume: 41, Issue:1

    Topics: Alanine; Animals; Bicarbonates; Blood Glucose; Carbon; Carbon Radioisotopes; Citric Acid Cycle; Diab

1982
Biochemical changes after surgical stress in rabbits.
    The Japanese journal of surgery, 1982, Volume: 12, Issue:1

    Topics: Alanine; Animals; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Diabetes Mellitus, Experimenta

1982
Decreased lactate transport in aortas from streptozotocin-diabetic rats.
    Blood vessels, 1982, Volume: 19, Issue:6

    Topics: Animals; Aorta; Biological Transport; Diabetes Mellitus, Experimental; Lactates; Lactic Acid; Male;

1982
Effect of sodium dichloroacetate on dental caries in diabetic rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1982, Volume: 14, Issue:8

    Topics: Acetates; Animals; Dental Caries; Diabetes Mellitus, Experimental; Dichloroacetic Acid; Lactates; La

1982
Factors affecting tryptophan-induced hypoglycaemia in rats.
    Biochemical pharmacology, 1982, Nov-15, Volume: 31, Issue:22

    Topics: Adrenalectomy; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Hormones; Hypoglyc

1982
Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells.
    Diabetes, 1981, Volume: 30, Issue:11

    Topics: Adenosine Triphosphate; Animals; Axons; Diabetes Mellitus, Experimental; Energy Metabolism; Lactates

1981
Activation of peritoneal macrophages during the prediabetic phase in low-dose streptozotocin-treated mice.
    FEBS letters, 1993, Jul-19, Volume: 327, Issue:1

    Topics: Amino Acid Oxidoreductases; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Interferon-ga

1993
Is glycolysis impaired in erythrocytes of diabetic rats?
    Biochemical medicine and metabolic biology, 1993, Volume: 50, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Blood Glucose; Bucladesine; Diabetes Mellitus, Experimental; E

1993
Stimulation of gluconeogenesis leads to an increased rate of beta-oxidation in hepatocytes from fasted diabetic but not from fasted normal rats.
    Biochimica et biophysica acta, 1995, May-11, Volume: 1244, Issue:1

    Topics: Adenosine Triphosphate; Animals; Antimycin A; Diabetes Mellitus, Experimental; Fasting; Fatty Acids;

1995
Catecholamine-induced cAMP response in streptozotocin-induced diabetic rat liver.
    The Tohoku journal of experimental medicine, 1994, Volume: 173, Issue:3

    Topics: Adipose Tissue; Animals; Colforsin; Cyclic AMP; Diabetes Mellitus, Experimental; Emaciation; Epineph

1994
Insulin-independent and extremely rapid switch in the partitioning of hepatic fatty acids from oxidation to esterification in starved-refed diabetic rats. Possible roles for changes in cell pH and volume.
    The Biochemical journal, 1995, Feb-01, Volume: 305 ( Pt 3)

    Topics: Animals; Carnitine O-Palmitoyltransferase; Cholesterol Esters; Diabetes Mellitus, Experimental; Este

1995
Mechanisms of intracellular pH regulation during postischemic reperfusion of diabetic rat hearts.
    Diabetes, 1995, Volume: 44, Issue:2

    Topics: Amiloride; Animals; Bicarbonates; Diabetes Mellitus, Experimental; HEPES; Hydrogen-Ion Concentration

1995
Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats.
    Diabetes, 1995, Volume: 44, Issue:2

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Neuropathies; Eye; Fructos

1995
Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs.
    Metabolism: clinical and experimental, 1994, Volume: 43, Issue:9

    Topics: Animals; Blood Glucose; Carbachol; Diabetes Mellitus, Experimental; Dogs; Fatty Acids, Nonesterified

1994
Chronic gliclazide treatment affects basal and post-ischemic cardiac function in diabetic rats.
    General pharmacology, 1994, Volume: 25, Issue:4

    Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus, Experimental; Gliclazide; Heart; Lactates; Lacti

1994
Sorbitol-accumulating pyrimidine derivatives.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:9

    Topics: Animals; Behavior, Animal; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Dose-Response R

1994
Improvement of ketoacidosis in the diabetic rat after the administration of the oral antilipolytic agent GR 79236.
    Clinical science (London, England : 1979), 1994, Volume: 86, Issue:5

    Topics: Adenosine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Fatty Aci

1994
Carbon sources for D-lactate formation in rat liver.
    Journal of biochemistry, 1994, Volume: 115, Issue:3

    Topics: Acetoacetates; Acetone; Animals; Diabetes Mellitus, Experimental; Glucose; Glycerol; In Vitro Techni

1994
Manifestations of diabetes mellitus on mouse preimplantation development: effect of elevated concentration of metabolic intermediates.
    Human reproduction (Oxford, England), 1994, Volume: 9, Issue:1

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Amino Acids; Animals; Butyrates; Cleavage Stage, Ovum; Culture

1994
Glucose, glycogen and triglyceride metabolism, as well as prostaglandin production in uterine strips and in embryos from diabetic pregnant rats. Influences of the presence of substrate in the incubation medium.
    Prostaglandins, 1993, Volume: 46, Issue:5

    Topics: Alprostadil; Animals; Culture Techniques; Diabetes Mellitus, Experimental; Dinoprostone; Female; Fet

1993
Ex vivo effect of insulin on normal and diabetic rat hearts hypoperfused with norepinephrine.
    European journal of pharmacology, 1993, Oct-05, Volume: 242, Issue:3

    Topics: Animals; Cerebrovascular Circulation; Diabetes Mellitus, Experimental; Energy Metabolism; In Vitro T

1993
Controlled release of insulin from plasma-irradiated sandwitch device using poly-DL-lactic acid.
    Biological & pharmaceutical bulletin, 1993, Volume: 16, Issue:2

    Topics: Adsorption; Animals; Blood Glucose; Buffers; Diabetes Mellitus, Experimental; Injections, Subcutaneo

1993
The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its transport system in rat livers.
    Diabetes research and clinical practice, 1993, Volume: 19, Issue:1

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Alanine; Animals; Biological Transport, Active; Buformin; Cell

1993
Streptozotocin-induced diabetes increases fructose 2,6-biphosphate levels and glucose metabolism in thymus lymphocytes.
    Life sciences, 1996, Volume: 58, Issue:6

    Topics: Animals; Carbon Dioxide; Diabetes Mellitus, Experimental; Fructosediphosphates; Glucose; Glycogen; G

1996
Experimental streptozotocin-reduced diabetes and intestinal glucose metabolism in the rat, in vivo and in vitro.
    Acta diabetologica, 1995, Volume: 32, Issue:3

    Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucose; Glycolysis; In Vitro Tech

1995
Role of high glycogen in underperfused diabetic rat hearts with added norepinephrine.
    Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:6

    Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus, Experimental; Energy Metabolism; Glycogen; Lacta

1995
Metabolism of glucose, glycogen, and high-energy phosphates during transient forebrain ischemia in diabetic rats: effect of insulin treatment.
    Anesthesiology, 1996, Volume: 84, Issue:4

    Topics: Adenosine Triphosphate; Animals; Brain; Diabetes Mellitus, Experimental; Glucose; Glycogen; Insulin;

1996
Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity.
    Metabolism: clinical and experimental, 1995, Volume: 44, Issue:12

    Topics: Amino Acid Sequence; Amyloid; Animals; Blood Glucose; Calcitonin; Diabetes Mellitus, Experimental; D

1995
Improvement of cardiac performance and metabolism in long-term diabetes mellitus after treatment with insulin [see comment].
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1995, Volume: 103, Issue:6

    Topics: Adenosine Triphosphate; Animals; Cardiac Output; Diabetes Mellitus, Experimental; Glucose; Heart; In

1995
Decreased myocardial glucose uptake during ischemia in diabetic swine.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:2

    Topics: Animals; Blood Glucose; Coronary Circulation; Diabetes Mellitus, Experimental; Fasting; Fatty Acids,

1997
Glucose transport and glucose transporter GLUT4 are regulated by product(s) of intermediary metabolism in cardiomyocytes.
    The Biochemical journal, 1997, Feb-01, Volume: 321 ( Pt 3)

    Topics: 3-Hydroxybutyric Acid; 3-O-Methylglucose; Animals; Biological Transport; Cells, Cultured; Deoxygluco

1997
Hepatic glucose production from L-alanine is absent in perfused liver of diabetic rats.
    Research communications in molecular pathology and pharmacology, 1997, Volume: 95, Issue:2

    Topics: Alanine; Alloxan; Animals; Anti-Bacterial Agents; Diabetes Mellitus, Experimental; Gluconeogenesis;

1997
Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:7

    Topics: Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; I

1997
Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat hearts.
    Journal of the American College of Cardiology, 1998, Mar-01, Volume: 31, Issue:3

    Topics: Adenine Nucleotides; Animals; Creatine; Creatine Kinase; Diabetes Mellitus, Experimental; Energy Met

1998
Changes in the redox state in the retina and brain during the onset of diabetes in rats.
    Neurochemical research, 1998, Volume: 23, Issue:6

    Topics: Animals; Cerebral Cortex; Diabetes Mellitus, Experimental; L-Lactate Dehydrogenase; Lactic Acid; Len

1998
Intramuscular 3-hydroxybutyrate levels after 60 tetani/min contraction in diabetic and non-diabetic rats.
    Endocrine journal, 1998, Volume: 45, Issue:3

    Topics: 3-Hydroxybutyric Acid; Animals; Diabetes Mellitus, Experimental; Lactic Acid; Male; Muscle Contracti

1998
Effect of L-arginine-nitric oxide system on chemical-induced diabetes mellitus.
    Free radical biology & medicine, 1998, Nov-01, Volume: 25, Issue:7

    Topics: Alloxan; Animals; Antioxidants; Arginine; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Insuli

1998
Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin.
    Diabetes, 1999, Volume: 48, Issue:6

    Topics: Animals; Citric Acid Cycle; Diabetes Mellitus, Experimental; Gluconeogenesis; Glucose; Glutamic Acid

1999
Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes.
    Cardiovascular research, 1999, Volume: 43, Issue:1

    Topics: Analysis of Variance; Animals; Diabetes Mellitus, Experimental; Glucose; Lactic Acid; Magnetic Reson

1999
Effects of anoxia on force, intracellular calcium and lactate production of urinary bladder smooth muscle from control and diabetic rats.
    The Journal of urology, 2000, Volume: 163, Issue:4

    Topics: Animals; Calcium; Cell Hypoxia; Diabetes Mellitus, Experimental; Glucose; Intracellular Fluid; Lacti

2000
Enhancement of fracture repair in rats with streptozotocin-induced diabetes by a single injection of biodegradable microcapsules containing a bone formation stimulant, TAK-778.
    Journal of biomedical materials research, 2000, Sep-05, Volume: 51, Issue:3

    Topics: Animals; Benzothiepins; Biocompatible Materials; Biodegradation, Environmental; Capsules; Diabetes M

2000
The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia.
    Brain research, 2000, Jul-28, Volume: 872, Issue:1-2

    Topics: Administration, Topical; Animals; Aspartic Acid; Blood Glucose; Brain Ischemia; Cerebral Cortex; Dia

2000
Effects of the dimethyl ester on succinic acid on the hormonal and metabolic response to exercise in hereditarily diabetic starved rats.
    Cell biochemistry and function, 2000, Volume: 18, Issue:3

    Topics: 3-Hydroxybutyric Acid; Animals; Body Weight; Diabetes Mellitus, Experimental; Fatty Acids, Nonesteri

2000
Acute diabetes modulates response to ischemia in isolated rat heart.
    Molecular and cellular biochemistry, 2000, Volume: 210, Issue:1-2

    Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Diabetes Mellitus, Experimental; Glycogen; Heart; Hear

2000
Lactate transport in rat adipocytes: identification of monocarboxylate transporter 1 (MCT1) and its modulation during streptozotocin-induced diabetes.
    FEBS letters, 2000, Aug-18, Volume: 479, Issue:3

    Topics: Adipocytes; Animals; Biological Transport; Blotting, Western; Brain; Carrier Proteins; Cell Membrane

2000
Correction of hyperglycemia and insulin sensitivity by T-1095, an inhibitor of renal Na+-glucose cotransporters, in streptozotocin-induced diabetic rats.
    Japanese journal of pharmacology, 2000, Volume: 84, Issue:3

    Topics: Animals; Carbonates; Deoxyglucose; Diabetes Mellitus, Experimental; Glucosides; Hyperglycemia; Hypog

2000
Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:12

    Topics: Administration, Oral; Animals; Blood Glucose; Chitin; Chitosan; Diabetes Mellitus, Experimental; Dis

2000
The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex.
    Neurosurgery, 2001, Volume: 48, Issue:2

    Topics: Acute Disease; Amino Acids; Animals; Blood Glucose; Brain Ischemia; Cerebral Cortex; Chronic Disease

2001
Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle.
    American journal of physiology. Endocrinology and metabolism, 2001, Volume: 280, Issue:5

    Topics: Animals; Biological Transport; Deoxyglucose; Diabetes Mellitus, Experimental; Enzyme Activation; Glu

2001
Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy.
    Pharmacology, 2001, Volume: 62, Issue:3

    Topics: Adrenergic alpha-Antagonists; Ammonia; Animals; Antioxidants; Cell Fractionation; Diabetes Mellitus,

2001
Streptozotocin-induced diabetes decreases rat sarcolemmal lactate transport.
    Metabolism: clinical and experimental, 2001, Volume: 50, Issue:4

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Down-Regulation; Glutathione P

2001
Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia?
    Basic research in cardiology, 2001, Volume: 96, Issue:2

    Topics: Animals; Blood Glucose; Coronary Disease; Diabetes Mellitus, Experimental; Glycogen; In Vitro Techni

2001
Rates of gluconeogenesis in perfused liver of alloxan-diabetic fed rats.
    Research communications in molecular pathology and pharmacology, 2000, Volume: 107, Issue:1-2

    Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Fructose; Gluconeogenesis; Glucose; Glutamine; In

2000
Simultaneous determination of D-lactic acid and 3-hydroxybutyric acid in rat plasma using a column-switching HPLC with fluorescent derivatization with 4-nitro-7-piperazino-2,1,3-benzoxadiazole (NBD-PZ).
    Biomedical chromatography : BMC, 2001, Volume: 15, Issue:3

    Topics: 3-Hydroxybutyric Acid; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimenta

2001
A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release.
    Journal of controlled release : official journal of the Controlled Release Society, 2002, Feb-19, Volume: 79, Issue:1-3

    Topics: Animals; Biocompatible Materials; Capsules; Chemistry, Pharmaceutical; Delayed-Action Preparations;

2002
Effect of endogenous beta-hydroxybutyrate on brain glucose metabolism in fetuses of diabetic rabbits, studied by (13)C magnetic resonance spectroscopy.
    Brain research. Developmental brain research, 2002, Apr-30, Volume: 135, Issue:1-2

    Topics: 3-Hydroxybutyric Acid; Amino Acids; Animals; Blood Glucose; Brain; Carbon Isotopes; Diabetes Mellitu

2002
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury.
    Diabetes, 2002, Volume: 51, Issue:5

    Topics: Animals; Cardiotonic Agents; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, T

2002
Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
    Journal of controlled release : official journal of the Controlled Release Society, 2002, Jun-17, Volume: 81, Issue:3

    Topics: Animals; Biocompatible Materials; Blood Glucose; Capsules; Crystallography, X-Ray; Delayed-Action Pr

2002
Effects of streptozotocin-induced diabetes on markers of skeletal muscle metabolism and monocarboxylate transporter 1 to monocarboxylate transporter 4 transporters.
    Metabolism: clinical and experimental, 2002, Volume: 51, Issue:7

    Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Carrier Proteins; Citrate (si)-Synthase; Diabetes M

2002
Glucose metabolism in embryos of normal and diabetic rats during organogenesis.
    Acta endocrinologica, 1992, Volume: 127, Issue:3

    Topics: Animals; Diabetes Mellitus, Experimental; DNA; Embryo, Mammalian; Embryonic and Fetal Development; G

1992
Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats.
    The American journal of physiology, 1992, Volume: 263, Issue:6

    Topics: Adenosine Triphosphate; Animals; Coronary Disease; Diabetes Mellitus, Experimental; Diabetic Angiopa

1992
Correlation of contractile dysfunction and abnormal tissue energy metabolism during hypoperfusion with norepinephrine in isolated rat hearts: differences between normal and diabetic hearts.
    Journal of molecular and cellular cardiology, 1992, Volume: 24, Issue:10

    Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus, Experimental; Energy Metabolism; Heart; Lactates

1992
Concentrations of D-lactate and its related metabolic intermediates in liver, blood, and muscle of diabetic and starved rats.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1992, Volume: 192, Issue:6

    Topics: Animals; Blood Chemical Analysis; Blood Glucose; Diabetes Mellitus, Experimental; Enzymes; Food Depr

1992
The effects of orthovanadate, vanadyl and peroxides of vanadate on glucose metabolism in skeletal muscle preparations in vitro.
    Molecular and cellular biochemistry, 1992, Feb-12, Volume: 109, Issue:2

    Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Glycogen; Insulin; Lactates; Lactic Acid; Male; M

1992
Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1992, Volume: 12, Issue:1

    Topics: Adenine Nucleotides; Animals; Arterial Occlusive Diseases; Blood Pressure; Body Temperature; Brain;

1992
Glucose and glutamine metabolism in rat macrophages: enhanced glycolysis and unaltered glutaminolysis in spontaneously diabetic BB rats.
    Biochimica et biophysica acta, 1991, Dec-06, Volume: 1115, Issue:2

    Topics: Adenosine Triphosphate; Ammonia; Animals; Aspartic Acid; Diabetes Mellitus, Experimental; Female; Gl

1991
Glutamine and glucose metabolism in thymocytes from normal and spontaneously diabetic BB rats.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 1991, Volume: 69, Issue:12

    Topics: Adenosine Triphosphate; Animals; Cell Count; Diabetes Mellitus, Experimental; Female; Glucose; Gluta

1991
Enhanced 2-deoxy-D-glucose uptake and metabolism in splenocytes from diabetic and diabetes-prone BB rats. Further evidence to support prior in vivo activation.
    The Journal of biological chemistry, 1991, Feb-25, Volume: 266, Issue:6

    Topics: Animals; Carbon Dioxide; Deoxyglucose; Diabetes Mellitus, Experimental; Female; Glucose; Lactates; L

1991
[The effect of exertion on carbohydrate metabolism in myocardium of animals with experimental diabetes].
    Folia medica Cracoviensia, 1990, Volume: 31, Issue:4

    Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Lactates; Lactic Acid; Myocardium

1990
Effect of insulin on glucose utilization in epitrochlearis muscle of rats with streptozocin-induced NIDDM.
    Diabetes, 1990, Volume: 39, Issue:9

    Topics: Adenosine Triphosphate; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus,

1990
Sustained release of insulin by double-layered implant using poly(D,L-lactic acid).
    Journal of pharmaceutical sciences, 1990, Volume: 79, Issue:6

    Topics: Animals; Blood Glucose; Body Weight; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experi

1990
Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes.
    Journal of applied physiology (Bethesda, Md. : 1985), 1985, Volume: 59, Issue:4

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Epinephrine; Fatty Acids, Nonesterifi

1985
Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Diabetes, 1988, Volume: 37, Issue:11

    Topics: Adipose Tissue; Animals; Benzopyrans; Blood Glucose; Chromans; Deoxyglucose; Diabetes Mellitus, Expe

1988
Pathways of acetone's metabolism in the rat.
    The Journal of biological chemistry, 1986, Mar-25, Volume: 261, Issue:9

    Topics: Acetone; Acetyl Coenzyme A; Animals; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Female;

1986
Mechanism of stimulation of liver glycogen synthesis by fructose in alloxan diabetic rats.
    Diabetes, 1986, Volume: 35, Issue:6

    Topics: Animals; Diabetes Mellitus, Experimental; Fructose; Glucose-6-Phosphate; Glucosephosphates; Glycogen

1986
Hepatic regeneration and metabolism after partial hepatectomy in diabetic rats: effects of insulin therapy.
    European journal of clinical investigation, 1986, Volume: 16, Issue:5

    Topics: Adenine Nucleotides; Animals; Diabetes Mellitus, Experimental; DNA; Glucose; Hepatectomy; Insulin; L

1986
In vitro insulin action on erythrocyte glucose metabolism in normal and diabetic rats.
    Diabetologia, 1988, Volume: 31, Issue:1

    Topics: Animals; Blood Glucose; Carbon Dioxide; Diabetes Mellitus, Experimental; Erythrocytes; In Vitro Tech

1988
Sensitive determination of D-lactic acid in biological samples by high-performance liquid chromatography.
    Journal of chromatography, 1988, Oct-14, Volume: 431, Issue:2

    Topics: Adult; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Humans; Hydra

1988
Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves.
    Experimental neurology, 1988, Volume: 99, Issue:1

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Biological Transport, Active; Diabetes Mellitus,

1988
Intermediary metabolism in diabetic dogs treated with pancreatic autotransplants and insulin pumps.
    Metabolism: clinical and experimental, 1986, Volume: 35, Issue:4

    Topics: 3-Hydroxybutyric Acid; Alanine; Animals; Diabetes Mellitus, Experimental; Dogs; Fatty Acids, Noneste

1986
The effects of lactate, acetate, glucose, insulin, starvation and alloxan-diabetes on protein synthesis in perfused rat hearts.
    The Biochemical journal, 1986, Jun-01, Volume: 236, Issue:2

    Topics: Acetates; Acetic Acid; Animals; Diabetes Mellitus, Experimental; Food; Glucose; Heart; Insulin; Lact

1986
Glycogenolysis and lactogenesis in the ischemic diabetic rat heart.
    Diabetes research (Edinburgh, Scotland), 1987, Volume: 4, Issue:1

    Topics: Animals; Coronary Disease; Diabetes Mellitus, Experimental; Fasting; Glycogen; Lactates; Lactic Acid

1987
Potential intercellular futile cycling of carbohydrates in diabetes.
    The Biochemical journal, 1987, Sep-01, Volume: 246, Issue:2

    Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Extracellular Space; Female; Gala

1987
Relationship between maternal and fetal fuels and placental glucose transfer in rats with maternal diabetes of varying severity.
    Diabetes, 1985, Volume: 34 Suppl 2

    Topics: 3-Hydroxybutyric Acid; Amino Acids; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female;

1985
Changes in the activity of 'active' pyruvate dehydrogenase complex in the newborn of normal and diabetic rats.
    Diabetologia, 1985, Volume: 28, Issue:3

    Topics: Animals; Diabetes Mellitus, Experimental; Dichloroacetic Acid; Enzyme Activation; Female; Glucose; I

1985
Effects of fructose feeding on lipid parameters in obese and lean, diabetic and nondiabetic Zucker rats.
    The Journal of nutrition, 1985, Volume: 115, Issue:10

    Topics: Animals; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dietary Carbo

1985
Effect of glucose and insulin administration on hepatic adenylate energy charge and the cytosolic redox state in the neonates of normal and insulin-treated diabetic rats.
    Biology of the neonate, 1985, Volume: 48, Issue:4

    Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Animals, Newborn; Cytosol; Diabetes Mellitus,

1985
Effects of alloxan-induced diabetes mellitus on the metabolism of the rat placenta.
    Archives of gynecology, 1986, Volume: 237, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Alanine Transaminase; Animals; Aspartate Aminotransfe

1986
Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy.
    The American journal of physiology, 1985, Volume: 248, Issue:4 Pt 1

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Diabetes Mellitus, Experimental; Diabetic Neurop

1985
Decreased uterine blood flow in the diabetic pregnant rat does not modify the augmented glucose transfer to the fetus.
    Biology of the neonate, 1985, Volume: 48, Issue:4

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Embryonic and Fetal Development; Female; Fe

1985